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EXECUTIVE SUMMARY
NASA scientists and physicians have been conducting research addressing the
formation and circulation of air emboli ("microbubbles") in an astronaut's bloodstream
when exposed to decreased atmospheric pressures. They have been especially concerned
with the potential for problems which circulating air emboli could cause during extravehic-
ular activity (EVA). To date, there have been no reports of symptoms commonly associat-
ed with circulating air emboli even though ground-based testing has predicted a significant
probability of such an occurrence. Research is continuing in this area, but is being ham-
pered by the lack of a reliable means of monitoring microbubbles in the space suit during
EVA.
In many research laboratories and clinical/surgical settings, circulating microbubbles
are routinely monitored using Doppler ultrasound techniques. NASA also has significant
experience with this morality in altitude chamber experiments. NASA Life Sciences
Engineering has consequently been directed to assess the potential for development of an
automated in-suit microbubble monitoring system. To this end, LSR, Inc. has been sub-
contracted by GE/Government Services to generate a report detailing potential in-suit
Doppler concepts and manufacturers.
LSR has completed this initial technology assessment and the results are detailed in
the accompanying report. We have fully researched all background resources available to
us and have contacted many cognizant researchers, scientists, and engineers to ascertain
the current status of research and the "state-of-the-art" in this field.
We have also completed a survey of over sixty manufacturers in the ultrasound
marketplace. We issued a "Request to Industry" which included a Questionnaire for ob-
taining basic information about each organization's experience and capabilities. In addi-
tion, we supplied a "specification" in our request. This specification was generalized be-
cause of many indeterminate parameters at the present time. We requested each organi-
zation to respond to this specification with a "Technical Approach" outlining potential
strategies to achieving the desired design.
We received full responses (that is, both Questionnaire and Technical Approaches)
to our Request from seven (7) organizations. We received partial responses from an addi-
tional eleven (11) organizations. As expected, based on the limited nature of the specifica-
tions, most responses were superficial. However, in the aggregate, they supplied us with a
very good overview of industry capabilities and potential approaches to a solution. We
also recognize that a number of organizations have probably chosen to withhold their
"best" ideas at this early stage of review.
During the course of our assessment, we have discovered many unanswered physio-
logical, medical, and engineering questions which must be addressed. Such basic physio-
logical questions as "What is the best anatomical site to non-invasively monitor circulating
EXECUTIVE SUMMARY (Cont'd)
air emboli?" are still being researched. The answer to questions such as this will obviously
have great impact upon the engineering design of an automated monitoring system. On
the engineering side, questions such as "How does one maintain a quality signal from the
preferred site during moderate body motion?" have yet to be adequately addressed.
Several organizations appear to have a very good grasp of the magnitude of the
multi-disciplinary problems associated with this development. We have rated all respond-
ing organizations and attempted to identify the most outstanding. With a major caveat
due to the preliminary and limited interaction which we have had with these organizations,
we feel that organizations such as Hoffrel Instruments (South Norwalk, CT), the Institute
of Applied Physiology and Medicine (Seattle, WA), and Medasonics (Freemont, CA) could
provide credible engineering efforts for this program. There are also a number of other
organizations which could conceivably provide a strong assault on this development.
We recommend that the development program should initially focus on a Feasibility
Phase conducted with minimally-modified, off-the-shelf-equipment. This phase will aim at
resolving the major unknowns, such as noted above.
The report presents an excellent overview of this field and will serve as a funda-
mental resource for the successful implementation of an in-suit ultrasound air embolism
monitor.
As a final overview, the following page presents a succinct, bullet-format,
itemization of the contents of this report.
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• Review and PresentBackground Research
• Survey Medical Ultrasound Marketplace
• Provide Recommendatiom for Future Efforts
REOUEST TO INDUSTRY
Questionnaire: Experience and CapabiLities
Technical: General Specifications
_StR,TS
• Over 60 Potential Manufacturers Identified
• 18 Questionnaire Responses
• 7 Technical Responses
• Significant Industry Interest
• Additional Limited Responses from Several Potential Vendors
• Commercial Product Spinoffs Seen as Important Incentive
• Wide Range of Capabilities, Experience, Technical Approaches
• Organizations Objectively and Subjectively Evaluated
• Organizations Ranked and Grouped

ACRONYMS
1G
2D
ASIC
CMOS
CW
DCS
DSP
ECLSS
EVA
LSR
MHz
NDT
RF
RFP
ROM
SAM
TCD
WETF
One times the force of Gravity
Two Dimensional
Application-Specific Integrated Circuit
Complementary Metal Oxide Semiconductor
Continuous Wave
Decompression Sickness
Digital Signal Processing
Environmental Control Life Support System
Extra-Vehicular Activity
Lovelace Scientific Resources, Inc.
Megahertz
Non-destructive Testing
Radio Frequency
Request for Proposal
Rough Order of Magnitude
School of Aerospace Medicine
Transcranial Doppler
Water Evaluation Test Facility

1.0 INTRODUCTION
1.1 Ob_iectives
The objective of this program was to perform a technology assessment survey of
non-invasive air embolism detection utilizing Doppler ultrasound methodologies. The
primary application of this technology will be as a continuous monitor for astronauts while
performing extravehicular activities (EVA's).
The technology assessment was to include:
1) development of a full understanding of all relevant background research and
2) a survey of the medical ultrasound marketplace for expertise, information,
and technical capability relevant to this development.
Upon completion of the assessment, LSR was to provide an overview of techno-
logical approaches and R&D/manufacturing organizations.
1.2 Methodology
--v
LSR initially performed a comprehensive literature survey to ensure that we were
fully acquainted with all relevant background literature. "This survey included searches of
the National Library of Medicine (Medline) database, several engineering databases, the
U.S. and World Patent databases, and various business/financial databases.
LSR also interviewed key NASA, other government, and private-sector scientists
and engineers who have been involved in air embolism research and development. This
step provided essential information. While many of these observations were unpublished
and anecdotal in nature, they nevertheless proved to be very useful.
It was also necessary to understand the constraints associated with the current
NASA space suit. Appropriate interfaces to cognizant NASA personnel were facilitated by
GE/Government Services in order for LSR personnel to assure compatibility of potential
approaches and recommendations with the suit environment.
Finally, based on the above foundation, LSR developed a comprehensive listing of
the manufacturers and research organizations with potential for development of the de-
sired air embolism monitoring system. We contacted each of these entities and begin to
assess their suitability for the proposed task. Among our concerns were items such as:
a) experience of key personnel in medical ultrasound,
b) experience in signal processing,
c) history and stability of the company,
d) ability/willingness to produce prototype units, and
e) experience with flight-rated (or near flight-rated) equipment.
To provide a more formal structure to this information gathering process, we devel-
oped a "Request to Industry" document which was sent to over sixty organizations. The
organizations were informed that this was not an official 'Request for Proposals" (RFP)
and that no funds were available for development. Nevertheless, we requested that each
organization provide us with information on corporate resources and technical approaches
to the problem. Estimated rough-order-of-magnitude (ROM) cost figures for a prototype
device were also elicited from each organization.
This report presents a compilation of our findings. We are hopeful that this assess-
ment will provide foundational material upon which a successful development program can
be built.
1.3
As we began this assessment, and expanding throughout our effort, we were im-
pressed with a broad range of questions which will have strong impact upon the engineer-
ing design effort. Many of these questions are itemized in section 4.2 (Key Issues for
Future Development) of this report. Obviously, resolution of these issues was beyond the
scope of this present task.
However, we have labored to provide a foundation upon which to build solutions to
these questions. To do so, we have focused the scope of this task on collecting and analyz-
ing information from potential manufacturers, assessing the current technological state-of-
the-art, surfacing as many pertinent issues as possible, and providing recommendations
which could assist NASA Engineering in addressing these questions.
The development of an in-suit Doppler bubble detection system for Extravehicular
Activity (EVA) will be a multi-disciplinary program with components encompassing both"
Life Science and Engineering fields. While treatment of the physiological issues was
beyond the scope of the present assessment, their significance was fully understood in
order to assure an accurate technology assessment.
2
2.0 BACKGROUND
To provide a comprehensive technological assessmentfor an in-suit monitor to
detect circulating air emboli, it was necessary to build a broad-based foundation. In order
to complete this task, we chose to scrutinize three different sources of information.
The first source was the published biomedical literature of the world, contained
primarily in the National Library of Medicine's Medline database. The second informa-
tion source was a more diverse group of databases available through the Dialog Informa-
tion Services network. This collection included databases more targeted to the engineering
literature, patent documentation, and corporate business information. The third informa-
tion source was through contacts with key scientists, engineers, and related personnel who
have first-hand experience in the air embolism research field. Our findings are summa-
rized in the following sections.
2.1 Medical Literature Review
Immediately after program initiation, we began an intensive medical literature
search in the specialized field of circulating air emboli in humans. Dr. Dick Greene, an
acknowledged expert in application of ultrasound methodologies to bloodflow and imaging,
was primarily responsible for collection, synthesis, and presentation of this vast amount of
information.
In this section, we present a distillation of the results of the literature survey. It is
formatted to provide a concise tutorial overview of the field. This review is specifically
targeted to the noninvasive Doppler ultrasound detection of human air embolism and its
application to microgravity decompression sickness (DCS).
2.1.1 Introduction
The selection of atmospheric pressures and gas mixtures for the Space Shuttle,
Space Station, and Space Suit depends on various engineering, safety, and cost consider-
ations. In general, as atmospheric pressure is reduced, the risk of nucleation of gas bub-
bles increases, thus increasing the risks of decompression sickness as described by
thermodynamic theory (1,2).
Various theoretical (3,4) and ground-based experimental (5-9) studies have suggest-
ed optimal operational procedures, including atmospheric pressure, gas mixtures, and
prebreathing algorithms to predict and minimize the risk of decompression sickness. Due
to limitations in Space Suit technology, low pressures (4-6 psia at 100% oxygen) are re-
quired to maintain the flexibility which is essential for extravehicular activities during space
missions (10,11). The problem of the competing factors of pressure versus mobility in
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Space Suit design has been exacerbated by the use of standard atmospheric pressure (14.7
psia) in the Space Shuttle. This relatively high initial pressure leads to increased pressure
gradients and thus the probability of DCS during EVA.
Ground-base studies have suggested that the incidence of graded DCS during EVA
should be approximately 25% (12). Nevertheless, both USA and USSR astronauts pres-
ently report no incidences of DCS during 30 and 65 EVA's, respectively (9). Due to their
moderating effects, in theory, on the nucleation of gas bubbles, limb constraint (13,14) and
microgravity (12) have been suggested as prophylactic inhibitors of symptomatic DCS
during EVA. Although difficult to document, the discrepancy between predicted and
actual reports of DCS during EVA may be caused, in part, by the inherent subjectivity and
unintentional under-reporting of incidences of DCS by astronauts (12).
Clearly, sensitive and specific physiological markers of subclinical and clinical DCS
during ground-based and microgravity studies are required to clarify the incidences and
pathophysiological sequelae of graded DCS.
2.1.2 Physiology
Despite many decades of study, the exact causal relationship of inert gas nucleation
(bubbles) and DCS is not clearly understood (15-17). Depending on many environmental
factors, either pre-existing microscopic nitrogen gas bubbles grow and coalesce or bubbles
form de novo in connective tissues of joints and in blood. As atmospheric pressure is
decreased, the level of supersaturation of nitrogen (the "R-value") and its surface tension
dominate the growth and formation of these bubbles (2). By poorly understood mecha-
nisms, joint soreness and pain (the "bends") can occur with severities generally proportion-
al to the intensity and timing of the decompression. Increasing formation and migration of
the gas emboli can create a graduation of symptoms from joint pain to convulsions and
even death (18) should the emboli accumulate in the central nervous system.
Due to the relatively small pressure gradients which occur in manned spaceflight
(approximately 15 to 4 psia) as compared to deep sea diving, only limb symptoms are
expected to occur (12). These joint symptoms are stratified as:
Grade 1: joint awareness
Grade 2: mild or intermittent pain
Grade 3: persistent pain which results in compromised movement (12).
Clearly, Grade 3 symptoms could jeopardize any EVA.
It is also assumed that: 1) the lungs will effectively filter all venous blood-borne gas
emboli (19), 2) no gas emboli will pass through any anatomical/physiological intracardiac
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shunt, and 3) arterial blood borne gas emboli will be minimal and inconsequential (20).
As previously stated, no highly reliable physiological marker of the _ presence
of either tissue-bound or blood-borne gas emboli is presently available.
Numerous empirical studies using various O2/N: mixtures for denitrogenation
before EVA (5,21-23) have been undertaken to minitmz"e the risks of DCS. Although it is
generally accepted that relatively rapid pressure reduction from ambient 14.7 psia to not
less that 7.8 psia, without denitrogenation, is safe and produces a DCS risk approaching
zero (3, 13), there is no clear consensus on the appropriate optimal procedures to imple-
ment for a minimal, predictable DCS risk (11). This lack of consensus is again driven by
the lack of an appropriate subclinical and clinical marker of the underlying pathophysio-
logical state of DCS.
2.1.3 Doppler Method
For many years, the need for an objective method to noninvasively detect the
presence, both qualitatively and quantitatively, of gas bubbles in human tissues (a physio-
logical marker) has prompted many attempts to use ultrasound (24-28). Because of the
large difference in acoustic impedances between gas bubbles and body fluids such as
blood, relatively high (10 - 20 db) increases in backscattered signals arise from bubbles
(29). These blood-borne bubbles create easily detectible Doppler frequency shifts (30)
although of the same frequency as the surrounding acoustic scatterers (red blood cells).
Indeed, the bubbles may create signal saturation of the Doppler audio spectrum.
The landmark publications of Spencer and Clarke (31) and Balldin and Borgstrom
(32) demonstrated the feasibility and usefulness of Doppler ultrasound to reliably detect
air-emboli in subjects with and without symptoms of DCS. A standard and subjective
grading system which was proposed by these early investigators is still used by experienced
operators. This grading is based on the Doppler audio signal (32):
Grade 0: Complete lack of bubbles
Grade 1: An occasional bubble signal within the cardiac motion signal with the
great majority of cardiac periods free of bubbles
Grade 2: Many, but less than half of the cardiac periods contain bubble signals
singularly or in groups
Grade 3: All of the cardiac periods contain "showers" or single bubble signals,
but not dominating or overriding the cardiac motion signals
Grade 4: The maximum detectable bubble signal sounding continuously
through systole and diastole of every cardiac period and overriding
the amplitude of the normal cardiac signal.
5
Due to its relative simplicity and noninvasive practicality, Doppler technique be-
came the method of choice for most laboratories (6,7,33,34). Generally, precordial appli-
cations of both continuous wave Doppler (easy to use, but unspecific) and pulsed wave
Doppler (improved spatial resolution, but more operator dependent) have been used to
mon/tor air-emboli in the pulmonary artery or right ventricular outflow tract of the heart.
This sample location was chosen to allow detection of bubbles at a central location where
all blood collects from the air-emboli generating limbs, especially the legs (12). The
precordial location also allows the Doppler transducer to be secured manually or by a
strap in a relatively stable and constrained body location. Commercially available
precordial (35, 36) and transcranial (37-39) units have become available for diving, aero-
space, and surgical applications. ..
Presently, research studies utilizing 2 to 4 Mhz pulsed Doppler detection of blood-
borne air emboli in the right heart by a precordial transducer provide the most practical
and reliable method of associating venous air emboli with DCS. The method is based on
the invalidated assumption of a strong pathophysiological or causal correlation between
venous bubbles and DCS. The relevant importance of intravascular bubbles (which are
Doppler-detected) and extravascular bubbles (which probably cause symptoms) is unclear.
Despite technical improvements over the last two decades, bubble detection (31)
and screening (32) with decompression has remained subjective and qualitative (40).
Unfortunately, present methods of bubble detection by Doppler remain relatively insensi-
tive and unspecific markers of DCS (35,41,42). Reported sensitivity and specificity of
bubble detection upon exposure to 4.89 psia were 77% and 61%, respectively (41). Conse-
quently, approximately 39% of subjects without DCS (Grade 0) will have detectable bub-
bles (Grade > 1). Conversely, approximately 23% with Grade 0 bubbles will exhibit DCS
symptoms (Grade > 1). Thus, the correlation of bubble scores with DCS is variable and
depends upon many factors, but predominately, the accuracy of Doppler signal analysis
and qualitative clinical symptom scoring (12,42,43).
In summary, although Doppler methods are presently the method of choice to
detect air emboli (35,39), they create a suboptimal physiological marker of the relationship
between gas nucleation and DCS. Computer control and analysis of Doppler shifted
frequency spectra (44,45) should improve the sensitivity, specifidty, and overall operational
reliability of air emboli detection and _. Contrary to a recent comparative
study (39), ultrasound sector _ of air emboli (speckle) in the right heart (contrast
echocardiography) may challenge standard Doppler methods in sensitivity and specificity of
bubble detection (46,47). Recently developed Doppler color flow imaging may also play a
role in bubble detection (48). Clearly, minimization and portability of these imaging
modalities must occur before their application can be made in space, particularly in the
Space Suit. Transesophageal detection would be impractical (49).
More basic ground-level (12) and microgravity studies (50) would be required to
improve our understanding of the relationship between venous bubble detection and the
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symptoms and clinical sequelae of DCS. Only with this information will the predictive
value of air embolism detection by Doppler ultrasound, or any other modality, become
operationally useful.
2.2 Other Database Searches
The literature survey detailed above was heavily reliant on numerous searches done
in the National Library of Medicine Medline database. Medline is the premier online
database of the world's biomedical literature.
We also surveyed several other online databases which are accessible through
Dialog Information Services. The purpose of these searches was to ascertain if there is
significant effort in the field of human air embolism detection being conducted in other
areas of either the public or private sector. Utilizing key words which were selected to
give a balanced search, ie., neither too broad nor too narrow in its results, we searched the
following databases:
at INSPEC - A database covering the physics, electronics, and computing litera-
ture.
b* Compendex Plus - A database providing coverage of over 4,500 engineering
journals, selected government reports and books.
Co Claims/U.S. Patent Abstracts - A database containing records from the
general, chemical, electrical, and mechanical sections of the U.S. Patent
Office.
d* World Patents Index - A database containing patent documents from over 30
patent issuing authorities around the world. Abstracts are available for
patents issued since 1981.
el Federal Research in Progress (FEDRIP) - A database providing access to
information about ongoing federally-funded research projects in the fields of
physical sciences, engineering, and life sciences.
Two search strings were submitted to each of these databases, without limitation of
field location or keyword context. This would result in the largest number of "hits" for
each database. These two search strings were:
a.
b.
(Doppler or ultrasound) and (bubble or air) and (blood or tissue)
ultrasound and transducer and blood flow and (diagnosis or monitor)
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The results of these searches produced a number of citations. Most of the hits were
either not particularly relevant to the in-suit Doppler bubble detection problem or were
previously uncovered in the Medline searches.
The patents database searches were more fruitful, however. In particular, we
discovered at least one patent which describes a multi-crystal, 2-dimensional, planar array,
ultrasound transducer which might have potential for the NASA in-suit Doppler applica-
tion. This 1985 patent (U.S. #4530363) details a transducer invented by A. F. Briskken
and assigned to the General Electric Company (Ultrasound Division). The text of this
patent is included in the appendix to this report.
2.3 Personal Interviews and Contacts
During the conduct of this study, we have had telephone conversations and meet-
ings with many knowledgeable individuals. In addition to many individuals at the manu-
facturing organizations which were surveyed, we have contacted three key personnel with
particular expertise in areas related to this effort. These individuals and the primary
insights gained from each are detailed in the following sections.
2.3.1 Michael Powell, PhD - NASA/SD-5
Dr. lowell, a primary NASA scientist in the area of air embolism research and the
author of a pending DSO proposal entitled "In-suit Doppler Ultrasound Monitoring: De-
tection of Gas Phase Formation in Microgravity _, was most helpful in discussing many
aspects of his research. In particular, LSR staff visited with Dr. lowell on two occasions
(October 3rd and 24th). On these occasions, we observed Drs. Poweli and Norfleet (a
coworker of Dr. Powell) conducting air embolism detection experiments using a Building
37 altitude chamber. These experiments were designed to mimic the decompression stress
which an EVA astronaut would incur under present suit/orbiter pressure timelines.
During these experiments, subjects exercised to varying degrees and pulmonary
artery bloodflow was monitored by a technician using a Medasonics "Transpect" Transcra-
nial Doppler Unit. This unit uses a Continuous Wave (CW) Doppler ultrasound technique
to transduce the velocity of targets within its beam. The Transpect emits a relatively
powerful ultrasound beam because it is primarily intended for transcranial applications.
For the precordial measurements of this experiment, its power was adjusted appropriately
downward. We observed the difficulty of reliably obtaining the desired bloodflow in some
subjects. It was also apparent that a trained ear was often necessary to detect the pres-
ence/absence of circulating microbubbles.
During a follow-up visit to Dr. Powell's laboratory, we discussed some of the ap-
proaches to online analysis of the blood flow signal which might lead to automated air
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emboli detection systems. The primary approach being pursued is to analyze the spectrum
of the Doppler audio signal.
2.3.2 Glen Lutz - NASA/EC
Mr. Glen Lutz provided insight into the current shuttle Space Suit during a meeting
with LSR and GE personnel on October 3, 1991. Mr. Lutz was extremely helpful and was
able to provide excellent information on the current operations of the suit as well as
potential modifications being considered. In particular, we were able to visualize the
potential volume available for an in-suit recorder within the hard upper torso of the suit.
We also discussed the present through-connector available for passing connections
between the inside of the suit and the ECLSS backpack. At present, no pins are available
on this connector, but a modification is being considered which would result in a larger
connector with additional pins.
2.3.3 Andrew Pilmanis, PhD - USAF/Armstrong Laboratory (SAM)
Dr. Andrew Pilmanis, scientist at the USAF/Armstrong Laboratory in San Antonio,
is also conducting research into air embolism detection for AF pilots. His background
includes research in diving applications before joining the Armstrong Laboratory staff. Dr.
Pilmanis has significant experience in ultrasound monitoring of bloodflow in order to
detect circulating air emboli.
Dr. Pilmanis explainedsome of the research ongoing at the Laboratory and noted
especially that they are becoming inclined to pursue an "imaging" approach to microbubble
detection. Blood flow imaging, in its simplest modality, involves analysis and display of the
amplitude of the demodulated RF echo signal. The amplitude of this demodulated echo
signal, which generally falls within the audio spectrum, exhibits great sensitivity to the
passage of microbubbles within the ultrasound beam. In essence, they feel that this detec-
tion scheme may be easier to use as a basis for automated detection than a scheme based
on the Doppler signal.
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3.0 REQUEST TO INDUSTRY
LSR developed a request for information which was sent to the broadest possible
contingent of potential organizations which might be interested in this development. The
full text of this "Request to Industry" is included in the Appendix to this report.
The purpose of this task was twofold:
1) Acquire objective data about the experience and capabilities of each
organization in areas related to this effort.
2) Obtain a cross-section of potential technical approaches to the
problem.
It must be emphasized that these technical approaches were based on a specifica-
tion which we supplied and was admittedly broad and incomplete in some key aspects.
Realizing this limitation, we intentionally directed each organization to supply its general
thinking in the form of a "White Paper" approach.
Before sending this document, each company was contacted by telephone, if possi-
ble, to determine a personal contact and to begin to determine a level of interest/expertise
for each organization.
3.1 Content of Request
The primary contents of the Request to Industry are outlined below. Section 3.1.1
describes the "Questionnaire" portion of the Request and Section 3.1.2 describes the "Spec-
ifications" portion. The specifications were given as general guidelines to be addressed by
each organization's Technical Approach.
3.1.1 Questionnaire
The Questionnaire portion of the Request to Industry asked the following questions:
1) How many years has your organization been in the ultrasound market-
place?
2) How many cumulative engineering person-years of experience does your
current staff have in design of medical ultrasound equipment?
3) Does your organization have experience in design of battery-operated,
medical, ultrasound equipment (Y/N)? If yes, approximately how many
cumulative engineering person-years?
11
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4)
5)
6)
7)
8)
Does your organization have experience in design of flight equipmem
(Y/N) ? ff yes, please explain.
Does your organizaa'on have experience in design of ultrasound eq-
uipment specifically.for circulating microbubble detection (Y/N) ? lf yes,
please explain.
What are your organization's unique strengths in the design of ultrasound
equipment?
What patents or intellectual property does your organization hold which
could be relevant to this project?
Will your organization be submitting a "Description of Technical Ap-
proach" by Friday, November 1, 1991 (Y/N) ?
3.1.2 Technical Approach
Each organization was requested to submit a "rechnical Approach" which would
outline the organization's general direction in the proposed development effort. The
technical approach was intended to indicate the level of experience and innovation within
each organization. LSR supplied a set of basic specifications, although very limited, in the
Request to Industry. Because there were, and continue to be, many areas requiring
further definition, the specifications were somewhat generalized. This led to a variety of
approaches within the various responses. The specifications supplied in the Request to
Industry are shown below. The drawing referenced in this section is included in Appendix
C of this report.
Introduction
This document is a broad definia'on of a small, battery-powered, ultrasound-
based instrument capable of monitoring micron-sized bubble activity in the
pulmonary artery bloodflow of an astronma in a Space Suit. Other monitoring
sites may also be considered. Once configured, the instrmnent must operate
unattended during E.uravehicular Activity.
In one potential configuration, the system would consist of a low-profile
transducer located on the astronaut's chest (worn under a cooling garment
made of a _spandex-like" material with imbedded tubing for citmdating water).
All processing electronics would also be located inside the Space Suit. The
output signal(s) may either be recorded on a small recording device/module
mounted inside the Space Suit or telemetered from the Space Suit.
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A concept utilizing a multiple-crystal transducer is shown in simplified form on
the attached drawing. This concept could potentially track a moving vessel
However, this is representative only, and any/all other approaches are welcome
and encouraget£
1) Transducer-to-Site Interface: self-attaching adhering. Stable and
continuously operable without operator manipulan'on after initial
attachment.
2) Artifact Rejection: Capable of continuously monitoring bubble activity
with little artifact during slow upper body movements.
3) Dynamic Range: Sufficient dynamic range to detect and record bubble
echoes without saturation or distortion.
4) Transducer Size: Low profile, comfortably worn under the cooling
garment.
5) Power: Battery-powered, minimum 6 hour capacity.
6) Weight: Breadboard < 3 lb
(Flight model weight less than 0.5 lb)
7) Volume: Breadboard < 50 cu. in.
(Flight model volume less than 5 cu. in.)
8) Operating temperature: 60- 100 OF (15- 38 *C)
9) Operating atmosphere: 100% Oxygen @ 4 psia
3.2 ONanizations Supplying Full Responses
Seven (7) organizations responded completely to our Request to Industry. Each
organization's response is summarized below. For ease of assimilation, we have distilled
the essence of each response and attempted to present each in a somewhat consistent
manner. The full, unabridged responses are included in the Appendix to this report.
There are many notable organizations which did not provide significant responses to
our Request to Industry. Many of the larger medical ultrasound organizations (Acuson,
ATL, Toshiba/Diasonics, GE, HP, Interspec, Philips, Siemens/Quantum, Shimadzu) were
among this group. It is expected that the R&D arms of the larger organizations cannot
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divert from their primary directions of development. They will not respond unless the
request is perceived to fail within a rather well-defined, pre-existing corporate strategy.
This is unfortunate because of the great amount of ultrasound design expertise which exists
within the larger organizations.
As for the responses which we did receive, it should be remembered that these
approaches were based on available information which is admittedly incomplete at this
point. As expected, the responses are generally lacking in specific detaiL Also, it might be
expected that many organizations simply chose not to provide proprietary information at
this early stage. Consequently, these responses should be viewed not as firm _proposais"
but rather as descriptive narratives of potential approaches to a solution. Any of these
responses could change significantly in response to a full RFP.
Also, because of the general nature of the specification, the organizations were only
requested to provide "Rough-Order-of-Magnitude" (ROM) pricing. This pricing should
therefore be viewed with caution. In addition, few organizations were comfortable in even
providing ROM cost of a flight-rated model. Most proposed a phased approach, with the
first phase being a feasibility study involving pre-prototype development. This stage would
be used as a proof-of-concept and would develop necessary data and experience for a
fully-operationai breadboard.
The organizations who responded both with answers to our Questionnaire and a
Technical Approach are presented in the following section (3.2.1). They are presented in
alphabetical order. These organizations are:
Hoffrel Instruments
IAPM
Medasonics
Medical Access. Inc.
Oxford/SonicaJd
Techno-Scientific
Universal Sonics
- South Norwalk, C'q"
- Seattle, WA
- Fremont, CA
- Trenton, NJ
- United Kingdom
- Woodbridge, Ontario
- Mahwah, NJ
Organizations which did not return a complete response are presented in section
3.3, again in alphabetical order.
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3.2.1 Hoffrel
3.2.1.1 The Approach
Hoffrel proposes a three phased approach to arrive at a working breadboard. This
approach is based on modification and application of existing Hoffrel technologies. The
Hoffrel strengths lie in 2D-knaging transducer design, mostly of the mechanical sector-scan
variety.
Hoffrel proposes to utilize a Doppler flowmetry-based system in contrast to an
"imaging" system, because a non-imaging system is more readily miniaturized. The
Doppler system would most likely be a pulsed design with bubble detection based on
analysis of the amplitude of the Doppler audio signal.
The first phase proposed by Hoffrel would be to adequately define the most advan-
tageous anatomical site for monitoring of bubble activity, assuming that this is not directed
by NASA staff. Hoffrel proposes a research program, most likely conducted in a 1G, alti-
tude chamber environment, which would elicit air-embolism activity. Hoffrel proposes to
utilize their transesophageal probe to closely monitor bubble activity within the heart.
This approach gives very high resolution views of the heart (more especially the left heart)
and would unequivocally detect bubble activity should it occur. Hoffrel is conducting
research studies in conjunction with a number of scientists interested in air embolism
detection and suggests that Dr. Charles Tegelar (Bowman-Gray School of Medicine) could
serve as an experienced medical consultant ff required in this initial phase.
The second phase of the program would be the modification of an existing precor-
dial, sector-scan transducer (small enough to fit between a surgeon's fingers) for this
application. The transducer presently operates at 5 MHz. Hoffrel would lower the oper-
ating frequency to achieve better penetration (due to less attenuation) and a somewhat
divergent beam (assuming the same crystal diameter) which would make positioning less
critical. Hoffrel would design a mechanical lock/attachment system to allow long-term
placement on the astronaut's chest. Use of a sector-scan transducer would allow real-time
adjustment of one axis of view, if necessary.
The third phase would be the design of the Doppler system. This would probably
be based around an Application Specific IC (ASIC) for the analog processing and a
CMOS microprocessor for control and data handling. At the end of this phase, a proto-
type of flight-size would be achieved.
Hoffrel estimates that these three phases would require 18 months of effort at a
ROM price of $306,000.
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3.2.1.2 The Company
Hoffrel employs approximately 12 people and is based in South Norwalk, CT.
Annual sales are approximately $1M. The company specializes in duplex-scanner trans-
ducer design and currently markets over 80 models for use with their own equipment as
well as that of other manufacturers. Hoffrel has been in the medical ultrasound market-
place for 28 years and has 46 years of cumulative engineering experience in design of
medical ultrasound equipment. In addition, Hoffrel has designed equipment which is used
specifically for air embolism detection in the medical market.
3.2.2 Institute of Applied Physiology and Medicine (IAPM)
3.2.2.1 The Approach
IAPM is proposing a system for realtime detection and quantification of air emboli
in the pulmonary artery. IAPM considered five key elements in their response:
lo Doppler electronics.
In recognition of the Space Suit constraints, IAPM notes that flammability
issues and static electricity issues must be recognized. For this reason, an
air-backed transducer might have to be sealed if used in this environment.
IAPM proposes to utilize a 2 - 2.5 MHz pulsed-Doppler system with a long
range-gate. This approach is used in IAPlVI's current transcranial doppler
design. The long range-gate approach is a compromise between a CW and
a conventional pulsed system which provides both a strong signal and rejec-
tion of the strong echoes from many static targets (such as vessel and cardiac
walls) in the beam path.
. Precordial transducer array and control electronics.
IAPM proposes a transducer comprised of a 2-dimeusional, planar array of
approximately 9 to 16 ultrasound crystals operated in a pulsed mode. These
individual crystals could be pulsed in synchrony, with continuous analysis Of
the remm signal from each, or a single crystal could be selected and activat-
ed. A long-term coupling medium could be comprised of the conductive
medium utilized for electrosurglcal grounding pads. These pads adhere well
to skin, yet do not extract significant amounts of body hair upon removal.
. Pattern recognition algorithm for identification of pulmonary artery blood-
flow.
IAPM expects that a predetermined location (1G experimentation) on the
astronaut's chest would be used for the 0G application. Also determined in
1G would be the characteristic waveform of the astronaut's pulmonary artery
bloodflow waveform. Using this predetermined waveform, IAPM would
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utilize principal-component analysis to assure that the signal obtained in 0G
was from the correct location. IAPM staff has experience with using the
principal-component technique in a non-invasive cardiac output monitor
which transduced aortic bloodflow through the suprasternal notch.
Pattern recognition algorithm for bubble detection and quantification.
IAPM has developed an algorithm for detection of air emboli and/or partic-
ulate reflectors in their Transcranial Doppler unit. They propose to adapt
this algorithm to the in-suit, precordial bloodflow application. The algorithm
is based on a matched filter approach (to the expected Doppler-spectral
composition of air emboli) and detection of increased amplitude of the de-
modulated Doppler audio signal. IAPM proposes that the processing/detec-
tion system could be located in the ECLSS backpack assuming that through-
connections are available from the interior to exterior of the Space Suit.
Recording and/or telemetry interface.
If telemetry from the Space Suit is not available, an on-suit recording/mem-
ory device will be required. For a 6-hour mission, intermittent recording will
probably be required to conserve power. Monitoring of 30-60 seconds every
15 minutes is proposed as a reasonable duty cycle. IAPM proposes that
processed data could be multiplexed onto the low frequency end of the voice
communication channel.
IAPM notes that the above development would require a three phase program with
the approximate level of effort and cost as shown below:
1. Development of a system with no size constraints (and based on existing
IAPM designs) which would be used for feasibility and proof-of-concept
testing.
.
3.
Effort: 11 person-months Cost: $125,000
Design and fabrication of a breadboard of required size.
Effort: 34 person-months Cost: $320,000
Development of the flight model.
Effort: not estimated Cost: not estimated
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3.2.2.2 The Company
IAPM employs approximately 20 people and is located in Seattle, WA. The
company has been in the medical ultrasound marketplace for approximately
20 years and has a cumulative 61 years of engineering experience in design
of ultrasound equipment. IAPM performed feasibility studies for
USAF/SAM on in-suit Decompression Sickness detection equipment in
1983-84. The company has experience in developing ultrasound equipment
and algorithms for detection of air emboli in the medical environment.
IAPM has conducted DCS research since 1971 in conjunction with Dr.
Merrill Spencer. Dr. Spencer is an acknowledged leader in this field, having
pioneered early efforts in the late 1960's.
Medasom_
The Approach
The Medasonics response was structured around three key topics:
. Existing Technology.
Medasonics proposes to base a design on existing electronics which are used
in their D-8 Versatone CW Doppler unit and Uniprobe system. The D-8 is
a universal analyzer/back-end for several probe modules which mate with it.
The Uniprobe is a handheld Doppler unit with electronics integrated into a
module approximately 0.75" x 4" x 0.5". Medasonics also currently manufac-
tures a 2.4 MHz transducer (approximately 1.3" diameter x 0.4" high) which
is specifically designed for right atrial bubble detection. The transducer
provides a very broad beam. The transducer is typically attached using
adhesive tape and is quite stable after attachment in an operating room
environment. Medasonics proposes to utilize these existing technologies to
develop an early breadboard which could be used for preliminary testing.
Medasonics also proposes to develop a transducer which could be place on
the astronaut's neck for monitoring of carotid artery flow. This location
would be used to detect arterial air emboli - which have much more serious
sequelae than the venous emboli monitored in the right heart.
Medasonics has developed an approach for detection of motion artifact
during ultrasound monitoring. This methodology is based on using Kynar
piezoelectric film which can be integrated with the transducer housing. The
output of this film can be used to indicate motion of respiratory or other
origin. This system could be used to provide a motion alarm or a "squelch"
signal for the ultrasound output.
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m Probe Development.
Medasonics has experience with mechanically-manipulated, auto-aiming
transducers in pulsed Transeranial Doppler systems. This technique did not
work well without operator intervention. Based on these efforts, Medasonics
feels that a multi-crystal, auto-aiming transducer approach will be poorly
suited to a precordial monitoring application. A wide beam transducer is
therefore proposed for the precordial position.
For the neck transducer, Medasonics proposes a linear array of crystals (not
a phased array, however) which could span a small length across the expect-
ed carotid artery. Either an appropriate crystal could be chosen, or all
crystals could be excited and the echoes analyzed for the desired flow signal.
Medasonics feels that this particular application has a very high degree of
commercialization potential for intraoperative use.
. Proposed Electronics
For the initial development phase (see below) Medasonics proposes to uti-
lize a modified Uniprobe electronics unit to drive both the precordial and
neck transducers. RF multiplexing circuitry would be developed. A micro-
processor would be used to perform transducer selection, spectrum analysis
to determine bubble activity, and recognition of motion artifacts. Outputs
would be the Doppler audio signals and a digital data stream for indicating
bubble detection and transducer location.
Medasonics proposes the following phases and ROM costs (based on an approach
which would potentially lead to a commercializable product):
It Concept Demonstration
Modify existing systems (1:'81 and P94A probes, separate Uniprobe electron-
ics for each probe, Cerebrovaseular Diagnostic System - CDS) and use in
altitude chamber tests. Develop algorithms for detection of bubbles and
rejection of motion artifacts.
Cost: $75,000
B Neck Probe Array and Electronics Breadboard
Develop neck probe array with integrated Kynar motion-detection film.
Develop multiplexed RF system to operate both precordial and neck probes
with one Uniprobe-based eleetonics system. Develop compact breadboard
version of embolism detection system.
Cost: $250,000
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3.2.3.2 The Company
Medasonics employs 150 people and is located in Freemont, CA. Medasonics has
been in the medical ultrasound marketplace for 21 years and has 18 years of cumulative
engineering experience. Medasonics has worked with NASA to deliver a Transcranial
Doppler for simulated 0G aircraft testing. They have also been associated with flight
hardware used in electromagnetic compatibility testing in the Skylab program (1972).
Medasonics markets Doppler ultrasound equipment designed specifically for air
embolism detection in the right atrium/pulmonary artery during neurosurgical procedures.
A TCD unit under development will include air/panicle embolic event detection as a
standard feature. A patent is pending for an air/particle embolism detector which mini-
mizes the effect of motion artifacts. Much of Medasonics' equipment is battery operated.
3.2.4 Medical Accessories, Inc. (MAI)
3.2.4.1 The Approach
MAI currently has a design for a 5 MHz ultrasound system which was evaluated at
NASA/JSC several years ago. MAI proposes to adapt this design for in-suit usage. Air
embolism detection circuitry would be designed and integrated with the basic Doppler
unit. MAI proposes to utilized rented spectrum analysis equipment in order to develop
algorithms for detection of bubble activity in the Doppler signal. This bubble detection
circuitry would automatically activate an internal recorder. MAI proposes to utilize
manually operated switches for system duty cycle control.
ROM cost for development to the prototype stage: $130,000.
3.2.4.2 The Company
MAI employs 40 people and is based in Trenton, NJ. The company has been in the
medical ultrasound marketplace for 16 years and has 84 years of cumulative engineering
experience. MAI has designed battery-operated ultrasound equipment for use in fetal
heart rate monitoring and blood pressure monitoring equipment. Company strengths are
in the areas of fetal heart rate monitoring, blood pressure monitoring, and air embolism
detection.
MAI has previously designed a 2.5 MHz ultrasound unit which was used for intra-
operative air embolism detection. This unit was marketed by Roche Medical Electronics
as the Embosonde 2000.
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3.2.5 Oxford/Sonicaid
3.2.5.1 The Approach
Oxford proposes to base an in-suit Doppler bubble detection system on an existing
design for intraoperative use. This design, marketed as Sonicaid's model D206 Air Emboli
Detector, utilizes a multi-crystal, wide-angle, low-profile transducer. Oxford would specifi-
cally address the issue of motion artifact rejection. Digital Signal Processing (DSP) tech-
niques would be used to automate the detection of air bubble signatures in the Doppler
signal. The existing I)206 is battery powered and presently operates continuously for
approximately 4 hours, although without an internal recorder. Design modifications could
extend this battery life.
Oxford proposes that a modified D206 unit be designed as an essential precursor to
development of a usable prototype. The modified D206 would be used in a proof-of-
concept phase where testing would be performed in a simulated EVA scenario, ie., in an
altitude chamber at 1G and/or the Water Evaluation Test Facility (WETF).
ROM Cost for development of modified D206: $55,000. Time: 20 weeks
3.2.5.2 The Company
Oxford acquired the Sonicaid company in 1989 and thus assumed a line of medical
ultrasound equipment. Oxford/Sonicaid employs 35 people and performs all R&D in the
UK. Sonicaid has been in the medical ultrasound marketplace for 20 years and has 50
years of cumulative engineering experience. Sonic.aid has developed ultrasound equipment
which has been used specifically for air embolism detection. Key strengths are in the
design of multi-crystal, wide-angle transducers and low noise analog signal processing
circuitry.
3.2.6 Techno-Scientific, Inc. (TSI)
3.2.6.1 The Approach
TSI proposes to base their design for NASA on an existing TSI unit. This unit is
the TSI DBM9008 ultrasound bubble detector. The basic DBM9008 is a 2.5 MHz, CW
Doppler design and provides an audio output only. The unit operates for approximately
I0 hrs. on a single 9V battery. The DBM9008 is designed for either preeordial right heart
or subclavian vein monitoring.
TSI provided, under previous contract to NASA, an "in-suit" version of this unit,
designated as the DBM9008i. The DBM9008i utilizes a smaller transducer (approx. 2era
x 3crn) than the DBM9008. The DBM9008i also contains an integral tape recorder.
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Formal documentation of the hardware evaluation is lacking at this time. Preliminary
results indicate suboptimal performance due to limitations of either design or application.
TSI proposes to modify the DBM9008i transducer to achieve a lower profile. The
CW approach will be retained as this is felt to provide more reliable bubble detection than
a pulsed design.
For development of a prototype unit which would be used for feasibility testing the
ROM cost is $75,000 to $120,000.
3.2.6.2 The Company
TSI employs five people and has been in the ultrasound marketplace for 10 years.
The company has a cumulative 20 years of medical ultrasound design experience. TSI has
experience in delivery of aerospace equipment to both NASA and Canadian organizations.
Key TSI capabilities are in the areas of transducer design and Non-destructive Testing
(NDT) utilizing ultrasound modalities.
3.2.7 Universal Sonics Corporation
3.2.7.1 The Approach
Universal proposes to utiliTe a CW Doppler unit with front-end electronics based
on existing design technologies. A transducer comprised of an array of split-crystals is pro-
posed, with each crystal being multiplexed sequentially. Each crystal output would be
demodulated and its output either recorded or telemetered to a Doppler Processing Unit
(DPU). This unit would not be located in the suit which would alleviate some of the
problems and cost of miniaturizing a complex analysis system. The suit would contain only
a Doppler Ultrasound Unit (DUU). The DUU would analyze the outputs from the vari-
ous crystals and output a bubble signal while rejecting signals from body motion.
Universal proposes a 3 phased effort:
. Feasibility Studies
This phase would aim at determining the optimum site for bubble detection
and the optimal ultrasound frequency for transduction of the blood/bubble
signal. This phase would also define the recording/storage requirements for
the system. Finally, phase 1 would assess the feasibility of meeting the
packaging and power requirements for in-suit usage.
Effort: 3 months Cost: $100,000
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. Breadboard Design
This stage would culminate with a working breadboard which would
approximate the size and power requirements of the final design. The
breadboard would be used for further ground-based testing.
Effort: 9 months Cost: $350,000
3. Flight-Model Design
Effort and Cost estimates not provided.
3.2.7.2 The Company
Universal Sonics employs 14 people and is located in Mahwah, NJ. The present
company has been in the medical ultrasound marketplace for 6 years, although many of
the engineers were previous employees of the Johnson & Johnson Ultrasound group.
Universal has a cumulative 98 years of medical ultrasound design experience. The have 2
years of design experience of battery-operated equipment. Universal engineers have
worked with RAFAEL (the Armament Development Authority of Israel) and have 10-20
years of experience in providing miniaturized, ruggedized flight equipment.
Universal currently provides custom ultrasound modules and assemblies to many of
the large OEM ultrasound companies. Universal's expertise is in the areas of Doppler RF
front ends, Doppler signal processing, and color flow-mapping modules. They have de-
signed a compact, low-noise, CW/Pulsed Doppler operating over the 2 to 10 MHz range.
3.3 Organizations Supplying Other than Full Responses
•Several other companies provided limited responses of varying degree to our Re-
quest to Industry. These companies were:
Applied Biometrics, Inc.
Advanced Technology Laboratories (ATL)
Biosound, Inc.
Carolina Medical Electronics
Diagnostic Ultrasound Corp.
- Eden Prairie, MN
- BotheU, WA
- Indianapolis, IN
- King, NC
- Kirkland, WA
23
Dymax Corp.
Eden Medical Electronics
Electro-Diagnostic Instruments
Elscint, Inc.
Hunfleigh Technology, Inc.
Kesa Corporation
Koven & Associates
(Hayashi Denki Co, Ltd. - HADECO)
Imex Medical Systems
Interspec, Inc.
Life-Tech, Inc.
Millar Instruments, Inc.
Minntech Corp.
Parks Medical Electronics, Inc.
Scientronics Mfg. Co.
Tetrad Corp.
Triton Technology, Inc.
Vistec/ETRA
Zevex, Inc.
- Pittsburgh, PA
- W. Germany
- Burbank, CA
- Hackensack, NJ / Israel
- Manalapan, NJ / UK
- Santa Clara, CA
- St. Louis, MO / Japan
- Golden, CO
- Ambler, PA
- Houston, TX
- Houston, TX
- Minneapolis, MN
- Aloha, OR
- St. James, NY
- Englewood, CO
- San Diego, CA
- Houston, TX
- Salt Lake City, UT
A brief summary of each of these company's response is presented in the following
sections.
3.3.1 Applied Biometrics,Inc.
Applied Biometrics acknowledged receipt of our Request to Industry.
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3.3.2 Advanced Technology Laboratories (ATL)
ATL acknowledged receipt of our Request to Industry and noted that this
development was not within its strategic business interests.
3.3.3 Biosound, Inc.
Biosotmd acknowledged receipt of our Request to Industry.
3.3.4 Carolina Medical Electronics (CME)
CME acknowledged receipt of our Request to Industry and provided an-
swers to our Questionnaire. CME has been in the medical ultrasound mar-
ketplace for 17 years and has 20 years of eurnulative engineering experience.
The company has no experience in design of battery-operated ultrasound
equipment but does have experience in aerospace flight-rated equipment. In
1983, CME designed a flight ready electromagnetic blood fiowrneter for use
by Dr. Phillip Hutchins and NASA.
CME has experience in design of equipment specifically for circulating mic-
robubble detection. In this regard, CME has received an NIH/SBIR grant
in collaboration with Dr. David Stump and Dr. Charles Tegelar, both of
Bowman Gray School of Medicine. CME has an active research program in
air embolism detection and various CME staff and other researchers have
published several articles in this field.
CME's primary expertise is in the area of electromagnetic blood fiowmeters.
CME now markets a color flow-mapping duplex Doppler system.
3.3.5 Diagnostic Ultrasound Corp. (DxU)
DxU responded to our Questionnaire. DxU has been in the ultrasound
marketplace for 7 years and has a cumulative 14 years of ultrasound design
experience. The company also has 14 years of experience in the design of
battery-powered ultrasound equipment. DxU has assisted in the develop-
ment of a catheter-based, air-emboli detection system.
DxU's strengths are in the area of small, hand-held, Doppler ultrasound
devices. They have designed pulsed Doppler circuits in integrated/hybrid
form which are used primarily in the Versadopp product line. A current 10
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MHz design features an electronics module of approximately 0.5" x 0.2" x
1.8" and consumes only 15 mA at 5V.
3.3.6 Dymax Corp.
Dymax acknowledged our Request to Industry and responded to our Ques-
tionnaire. Dymax has been in the medical ultrasound marketplace for 12
years and has 10 years of cumulative engineering experience in the ultra-
sound field. Dymax developed a Light-weight (7 lbs), battery-powered ultra-
sound scanner which has been marketed since 1986. Dymax is currently
developing a new generation scanner. Dymax has several patents on single-
moving part mechanized sector probes and on Tissue Signature Transceivers.
Dymax strengths are in the area of mechanical sector scanning probes with
only a single moving part. Dymax is a leading OEM suppLier of these
probes. Dymax may be the only manufacturer of a battery-powered, sector
scanner unit.
3.3.7 Eden Medical Electronics (EME)
EME acknowledged our Request to Industry and responded to the Question-
naire and provided a commentary on EME's background and experience in
the air embolism field. EME has been in the medical ultrasound market-
place for 9 years and has 60 years of cumulative engineering experience in
the design of medical ultrasound equipment. E/VIE has 10 years experience
in the design of battery-powered ultrasound devices.
EME has participated with NASA in the design/modification of Transeranial
Doppler (TCD) Systems (the EME TC2-64). This is a 2 MHz, pulsed
Doppler design. This system was flown on STS-29 (1989) and used in
experiments conducted by Dr. Jim Bagian. EME has obtained a number of
patents related to the mechanical aspects of transducer fixation.
Dr. Alec Eden, Chairman of EME's Scientific Advisory Board, has been a
pioneer in both TCD research and intraoperative air-embolism research.
Dr. Eden feels that EME could and would effectively respond to an RFP for
the design of the in-suit Doppler system. In addition, based on his experi-
ence, he notes that a multi-crystal transducer design is unnecessarily compli-
cated. Because of the envisioned size and power constraints, he would opt
for a simpler design.
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3.3.8 Electro-Diagnostic Instruments
Electro-Diagnostic Instruments acknowledged receipt of our Request to
Industry.
3.3.9 Elscint, Inc.
Elseint acknowledged receipt of our Request to Industry and responded to
our Questionnaire. Elseint has been in the medical ultrasound marketplace
for 12 years and has 75 years of cumulative engineering ultrasound design
experience. Elscint is a broad-based medical imaging company (MRI, Nu-
clear Medicine, Ultrasound) and markets heavily in Europe. In the ultra-
sound market, Elscint specializes in high-resolution, transvaginal imaging and
has several patents in this area.
Elscint does not feel that the in-suit Doppler bubble detection system coin-
tides with its product line and expertise.
3.3.10 Huntleigh Technology, Inc.
Huntleigh acknowledged receipt of our Request to Industry and responded
by noting that they would be interested in responding to a future RFP.
3.3.11 Kesa Corporation
Kesa acknowledged receipt of our Request to Industry and responded to our
Questionnaire. Kesa has been in the medical ultrasound marketplace for 10
years and has 15 years of cumulative engineering experience in this field.
They have designed battery-powered equipment and have 5 years experience.
Kesa has experience in both CW and pulsed Doppler designs.
Kesa strengths are in the areas of ultrasound transmitters/receivers, trans-
ducer design and interfacing, and magnetics design. Kesa currently has a
battery-operated, single crystal CW Doppler prototype (patented) which has
been used in animal labs for vessel location and blood flow evaluation. This
design is the only known implementation of a single-crystal CW Doppler
design capable of measuring both forward and reverse flow.
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3.3.12 Koven & Associates (Hayashi Denki Co, Ltd. - HADECO)
Hayashi Denki (via Koven & Associates) acknowledged receipt of our Re-
quest to Industry and responded to our Questionnaire. Hadeco has been in
the ultrasound marketplace for 35 years, has 250 years of cumulative engi-
neering design experience and 250 cumulative years of battery-powered
ultrasound system design experience.
Hadeco has experience in development of Doppler ultrasound equipment for
deep sea microbubble detection (for animal testing only). Some of this
technology and experience could be transferable to an in-suit Doppler sys-
tem for NASA.
Hadeco strengths are in the area of CW blood flow detectors based on
battery operation. Hadeco produces a line of instruments ranging from 2 to
10 MHz for blood flow velocity detection and blood flow volume measure-
ment.
3.3.13 Imex Medical Systems
Imex acknowledged receipt of our Request to Industry.
3.3.14 Interspec, Inc.
Interspec acknowledged receipt of our Request to Industry.
3.3.15 Life-Tech, Inc.
Life-Tech acknowledged receipt of our Request to Industry.
3.3.16 MiUar Instruments, Inc.
Millar acknowledged receipt of our Request to Industry.
3.3.17 Minntech Corp.
Minntech acknowledged receipt of our Request to Industry.
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3.3.18 Parks Medical Electronics, Inc.
Parks acknowledged receipt of our Request to Industry and responded to
our Questionnaire. Parks has been in the ultrasound marketplace for over
20 years and has over 30 years of cumulative engineering experience in the
design of medical ultrasound experience. Parks also has over 30 years cumu-
lative experience in the design of battery-powered ultrasound equipment.
The Parks model 915A-L has been used for monitoring microbubbles in
intraoperative applications. Parks' strengths are in the area of low-current,
battery-powered ultrasound equipment. Parks manufacturers its own probes
for all of its equipment.
3.3.19 Scientronics Mfg. Co.
Scientrouics acknowledged receipt of our Request to Industry and responded
to our Questionnaire. Seientronics had been in the ultrasound marketplace
for 6 years. The company has 30 years of cumulative design experience of
battery-powered ultrasound equipment. They have designed a probe for use
in the detection of circulating mierobubbles. Seientrouics holds a patent for
a 2 MHz ultrasound cuff probe.
3.3.20 Tetrad Corp.
Tetrad acknowledged receipt of our Request to Industry and noted that they
would be interested in responding to an RFP. Tetrad is an independent
design organization which designs custom ultrasound modules and equip-
ment for OEM manufacturers.
3.3.21 Triton Technology, Inc.
Triton acknowledged receipt of our Request to Industry.
3.3.22 Vistec/ETRA
Vistec acknowledged receipt of our Request to Industry and responded to
our Questionnaire. Vistec has been in the ultrasound marketplace for 22
years and has 45 years cumulative engineering experience in the design of
medical ultrasound equipment. Vistec has 12 years experience in design of
battery-powered ultrasound equipment.
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Vistec has designed aerospace flight equipment including a visual display
device to predict unconsciousness.
3.3.23 Zevex, Inc.
Zevex acknowledged receipt of our Request to Industry and responded to
our Questionnaire. Zevex has been in the medical ultrasound marketplace
for 5 years and has 75 cumulative years of engineering experience in this
field. Zevex has experience with flight equipment, having supplied ultrasonic
air-bubble detection systems (for flowing fluids) on the Space Shuttle.
Zevex's major strengths are in the design of ultrasound applications involving
air detection in fluids.
3.4 Discussion of Organizations and Approaches
As expected (and desired), our Request to Industry elicited a broad range of re-
sponses from interested organizations. This range of responses has been helpful in assess-
ing the state-of-the-art in this field and understanding the hurdles which must be overcome
for a successful development.
The previous section has presented our summary of the responses from the listed
organizations. Please see the Appendix for copies of the unabridged responses from each
organization. In this section, we discuss the various approaches and organizations.
3.4.1 Objective Organizational Data
For the organizations providing either full or partial responses, the table on the
following page summarizes each organization's experience, capabilities, and resources.
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ORGANIZATIONAL DATA
NAME A B C D E F G
Carolina Medical Electronics 17 20 N Y Y N
Diagnostic Ultrasound Corp. 7 14 Y 14 N Y N
Dymax Corp. 12 10 Y 10 N N N
Eden Medical Electronics 9 60 Y 10 Y Y N
Elscint 12 75 N N N N
Hoffrel 28 46 N - N Y Y
IAPM 20 52 Y 37 Y Y Y
Kesa Corp. 10 15 Y 5 N N N
Koven and Associates (Hadeco) 35 250 Y 250 N Y N
, ,. , i
Medasonies 21 18 Y 3 Y Y Y
Medical Accessories, Inc. 16 84 Y 84 Y Y Y
Oxford/Sonic,aid 20 50 Y 20 N Y Y
Parks Medical Electronics 20+ 30+ Y 30+ N Y N
Seientronics ManuL Co. 6 30 Y 30 N Y N
Techno Scientific, Inc. 10 20 Y 3 Y Y Y
Universal Sonics 6 98 Y 2 Y Y Y
Vistec/ETRA 22 45 Y 12 Y Y N
5 75 N - Y Y NZevex
A o
B-
C .
D .
E-
F-
G .
QUESTION CODING
How many years has the organization been in the ultrasound marketplace?
How many cumulative engineering person-years of experience does the cur-
rent staff have in designing medical ultrasound equipment?
Does the organization have experience in design of battery-operated, medi-
cal, ultrasound equipment?
If yes to (C), how many cumulative engineering person-years?
Does the organization have experience in design of flight equipment?
Does the organization have experience in design of ultrasound equipment
specifically for circulating microbubble detection?
Did the organization submit a "Description of Technical Approach"?
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To derive a somewhatobjective evaluation of the matrix above,we have attempted
to calculate a "score" for each of the eighteen organizations. In order to do this, we first
calculated a weighting factor for the Yes/No answers. To derive the value of the
weighting factor, we calculated the mean of all numerical entries in the table, ie., columns
A, B, and D. The mean of all these entries was 33. Using this weight, "Y" answers were
calculated as 33, and "N" answers as 0.
Secondly, numerical data (Columns A, B, and D) were ranked into High (=33
points), Moderate (= 16.5 points), and Low (=0 points) ranges. To assign values, each
column was sorted in numerical order. Then the eighteen organizations were divided into
three groups. In cases of two organizations with equal scores falling across a group
boundary, both organizations were assigned to the higher group.
The results of this "scoring" are shown in the following table. The scores indicate
an approximate four to one range from highest to lowest.
While this approach obviously cannot be defended in a rigorous manner, it does at
least provide a first attempt at evaluating these organizations in areas which will be
important to this development.
Importantly, it should be noted that the rankings rely heavily on a "self-assessment"
by each manufacturer. For this reason, we do not place too heavy an emphasis on these
results. In particular, "outlying" values, as in any data set, should be examined critically.
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QRGANIZATIQNAL RANKINGS
NAME RELATIVE "SCORE'
Inst. of Applied Physiology and Medicine 214
Medical Accessories, Inc. 214
Oxford/Sonicaid 181
Medasonics 181
Koven/Hadeco 165
Vistec 165
Universal Sonics 165
Teclmo Scientific Inc. 165
Parks Medical Electronics 148
Eden Medical Electronics 148
Hoffrel Instruments 115
Scientronics Manuf. Co. 115
Zevex 99
Diagnostic Ultrasound Corp. 82
Carolina Medical Electronics 82
Kesa Corp. 66
Dymax 66
Elscint 50
3.4.2 Subjective Evaluation of TechnicalApproaches
Most organizations have proposed a phased approach to a final, flight-rated assem-
bly. In addition, most organizations have recognized the need for additional basic research
in the areas of preferred monitoring site, transducer design, and bubble detection algo-
rithm development.
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The organizations with current commercial products which are being used in air
embolism detection are of particular interest in the current development. An organization
with relevant experience in this field will be most likely to have a more complete apprecia-
tion for the potential problems. These organizations are listed in the previous table with
an indication of "Y" in colunm F.
Overall, it is difficult to judge the submitted Technical Approaches because of the
general nature of their content. This does not reflect negatively on any particular organi-
zation and was to be expected due to the incomplete nature of the specifications which we
supplied. Moreover, it is possible that some organizations chose to withhold their best
ideas in this current "open" environment where any response could conceivably be avail-
able to a future competitor.
The key determinants of success for this development can be categorized in the
following areas:
Applicable Experience
Understanding of the Problem
Expertise, demonstrated
Understanding of Flight Qualification Requirements
Willingness to Cooperate
Based on the responses submitted, conversations with key corporate personnel, and
personal experience and observations, we felt that some organizations appeared to display
a more complete understanding of the field and of the potential problems in this develop-
ment. After evaluating each organization, albeit subjectively, in the areas listed above,
several organizations again appear to stand out. These organizations were Hoffirel, IAPM,
and Medasonics.
Beyond these three however, we feel that most organizations which market a prod-
uct for air embolism detection could confidently respond to an RFP. From the table
above, fifteen organizations responded that they currently manufactured such a product. It
is an encouraging prospect that this much basic expertise is available.
It should also be noted that many other organizations could supply a more complete
proposal in a competitive RFP environment. It is LSR's assessment that, based on
personal conversations and knowledge of these organizations, there are other organiza-
tions capable of responding who may not have done so in this open environment. Among
these organizations are Eden Medical Electronics, Parks Medical Electronics, and Tetrad.
In summary, the Request to Industry has served its purpose of a) acquiring data on
the experience and capabilities of many ultrasound manufacturing organizations and, b)
eliciting a number of technical discussions aimed at providing an in-suit ultrasound air
embolism detection system.
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4.0 SUMMARY AND RECOMMENDATIONS
We have developed a thorough understanding of the field of circulating air embo-
lism research and, in particular, its detection and quantification with ultrasound techni-
ques. We have reviewed the medical literature, talked with experts in the field, contacted
numerous organizations capable of providing hardware for measuring in-suit air emboli
during EVA, observed ongoing air embolism research at NASA/JSC altitude chambers,
and surveyed many databases for technology relevant to the proposed development. This
section presents our summary and recommendations base on the best available informa-
tion.
4.1 Orzanizational Groupings
We have identified several organizations with high potential for providing quality
hardware. Although extremely difficult to judge based upon the limited information which
we have from these vendors, we feel that several organizations which responded to our
Request to Industry fall into a group which we could categorize as "most likely" to be able
to produce a flight-rated, in-suit ultrasound bubble detector. These organizations, in our
judgment, are Hoffrel, IAPM, and Medasonics.
There are several other organizations that market ultrasonic bubble detection
devices or systems. These organizations, in addition to the four listed above, are Carolina
Medical Electronics, Diagnostic Ultrasound Corp., Eden Medical Electronics, Koven
(Hadeco), MAI, Oxford/Sonicaid, Parks Medical Electonies, Seientronics, Techno
Scientific, and Vistec. With this experience, many of these companies have potential for
excellent work in this field.
There is a third group of organizations for which we have very little information.
These organizations either gave little or no response to our request. In the event that a
competitive bid is solicited, it is possible that a significant proposal could come from this
group.
4.2 Key Issues for Future Development
As we have found in our literature searches, seen in altitude chamber testing at
NASA, and indicated in the responses from industry, a number of key issues are yet to be
resolved in this development. Unqualified answers to the following questions are critical
to program success.
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What is the best/preferred anatomical site for bubble observation? Should
only venous circulation be monitored or should arterial circulation also be
considered?
Is continuous monitoring required? If intermittent monitoring is acceptable,
what is an acceptable duty cycle?
How difficult is it tO acquire and maintain a quality signal from the prefer-
red site during moderate body movement over extended periods of time?
Is Doppler ultrasound or Echo ultrasound most likely to succeed in provid-
ing definitive recognition of circulating microbubbles?
Is pulsed or continuous wave Doppler the best modality?
Is automated, real-time bubble detection required? If so, can the detection
system be located off-suit?
Is telemetry available from the Space Suit and/or is an in-suit recorder
and/or memory system required?
What Space Suit constraints (voltage, interfaces, Oa environment) will have
the greatest impact on the in-suit design?
The following section outlines our recommendations for a rational approach for
resolving these questions.
4.3 Recommendations for Next Phase
As determined from responses to the Request to Industry, as well as LSR's experi-
ence in program development, there are a number of key steps which must be accom-
plished in order to successfully implement an in-suit Doppler bubble detection system.
Some of these steps are obviously the responsibility of NASA Science, while others fall
into the area of Engineering.
It is our observation that a significant amount of basic research should be complet-
ed before flight hardware should be requisitioned. At this time, it is premature to expend
large amounts of funds for customized hardware. It is our recommendation that a well-
planned program of laboratory testing, utilizing off-the-shelf equipment with limited modi-
ficatious, be undertaken. This is the "Feasibility Phase" and would, at a minimum,
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endeavor to answer the engineering questions outlined below. Following a successful
Feasibility Phase, the Breadboard and Flight Equipment Phases logically follow.
I,
lid
III.
Feasibility Phase
a. Select a plurality of vendors to provide modified off-the-shelf equip-
ment for laboratory experiments.
b. Determine anatomical site(s) for measurement
c. Determine most stable transducer/probe assembly design
d. Determine ultrasound modality for best reliability/signal quality
e. Determine if automated bubble detection is feasible/desirable.
L Determine data storage requirements
Breadboard Phase
g. Design breadboard
h. Tests in altitude chamber/WETF
i. Modify breadboard, if required
Hight Model Phase
j°
k.
1.
Design flight model
Tests in altitude chamber/WETF
Hight Qualification
To proceed with the Phase I Feasibility Testing, we recommend that organizations
supply modified off-the-shelf hardware which is capable of meeting certain minimal specifi-
cations. Within budget constraints, NASA should consider acquisition of hardware from
more than one vendor. This would enable the utilization and evaluation of a range of
approaches. This hardware would then be evaluated in a laboratory setting by highly-
trained personnel, under well-controlled conditions, with a protocol designed to address
the critical issues itemized under the Feasibility Phase.
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APPENDIX B
Definitions of Terms

Air emboli - A small circulating bubble of gas which, when spontaneously occuring in the
human body, is probably in the micron-size class and consisting largely of nitrogen gas. The
majority of air emboli are harmlessly f'dtered by the lungs.
Aorta - The main blood vessel carrying oxygenated blood away from the heart to the body
tissues.
Arterial circulation - The blood vessels which carry blood _ from the heart. This may
be either oxygenated blood (to the body tissues via the Aorta) or deoxygenated blood (to
the lungs via the Pulmonary Artery). Normal pressures range from 140 to 10 mmHg.
Backscatter - Scattering of ultrasound at an angle of 180 degrees to the beam direction.
Generally created by scatterers with dimensions similar to the wavelength of the ultrasound
wave.
Color Flow-mapping Doppler system - A duplex system capable of displaying a sector-scan
image and a superimposed color-coded flow velocity created by a multi-gated pulsed
Doppler. Both are typically shown in real time at 15 -20 frames/sec.
Continuous wave (CW) ultrasound - A system employing an uninterrupted transmission of
ultrasound energy accompanied by a continuous reception of reflected ultrasound, normally
by separate, isolated crystals. The sampling region is fixed and determined by the
intersection of the transmitting and receiving beams. Spatial resolution is limited in spite
of improved Signal-to-Noise ratios and maximal temporal and velocity resolution.
Decompression sickness (DCS) - The classical term applied to the spectrum of symptoms
elicited when gas-laden tissues are brought to a lowered atmospheric pressure. Clinical
manifestations may range from mild joint-awareness, through debilitating pain, to
unconsciousness and death.
Doppler System - An ultrasound system capable of transducing blood flow velocity
information based upon the Doppler principle whereby ultrasound reflected from a moving
target is shifted in frequency (relative to the incident frequency).
Duplex Scanner - An ultrasound system capable of displaying both imaging ("echo") and
blood velocity ("Doppler") information.
Fast Fourier Transform - A numerical algorithm to compute the frequency components
present in a function. The FFT produces an estimate of the relative amplitude of each
frequency component and is a standard method in Doppler signal processing.
Formed-element emboli - In contrast to an air-embolus, this is a small circulating mass
which, when spontaneously occuring in the human body, is probably a solid component. As
with air emboli, formed-element emboli are filtered by the lungs on the venous side.
Arterial formed-element emboli are much more dangerous and can occlude blood flow to
regions of the brain, thus creating "strokes."
Gas nucleation - Formation and growth of gas phase regions in a supersaturated liquid
medium.
Imaging System - An ultrasound system capable of displaying the amplitude of the signal
reflected from interior reflectors. The ultrasound beam is usually swept across an arc
(either mechanically by a motor-driven crystal assembly or electrically with a phased array)
at a rapid rate (12-42 frames/sec). The image is derived by displaying the amplitude of the
returned signal in a gray scale. (The simplest "image" is one-dimensional and COnsists of an
amplitude versus time display - known as an "M-mode'.)
Intraoperative - Pertaining to procedures performed during surgery.
Precordial - Pertaining to the area "before" the heart or, in the ultrasound context, the
external chest wall over the heart but left of the sternum.
Pulmonary artery - The blood vessel which carries deoxygenated blood from the fight
ventricle of the heart to the lungs for oxygen and carbon dioxide transfer. It is generally 5-8
centimeters long and 2 centimeters in diameter before it bifurcates into its left and right
branches to the respective lungs.
Pulsed ultrasound - A system employing a single piezoelectric crystal for both transmitting
and receiving the ultrasound energy. The crystal is time multiplexed between a relatively
short transmitted signal (typically 1 - 100 microseconds) and a much longer receiving period
(typically 1 - 100 milliseconds). The sampling region (sample volume) can be electrically
controlled and placed anywhere along the transducer beam for optimal range/spatial
resolution at the expense of temporal and velocity resolution.
Range Gate - In a pulsed Doppler system, the period of time after the transmit pulse during
which the receiver is enabled and the reflected signal is captured. Varying the delay
between the transmitted pulse and the opening of the range gate allows reflected signals
from varying depths to be analyzed.
Right ventricular outflow tract (RVOT) - The flow channel between the heart's right
ventricle and the pulmonary valve and artery. It is generally 3-5 centimeters long and 2
centimeters in diameter.
Sample Volume - The region in the ultrasound beam from which the Doppler signals are
detected.
Saturation signal - Large value of the Doppler signal that cannot be accomodated by the
receiver. Often occurs in bubble detection by Doppler.
Transcranial Doppler (TCD) - An ultrasound system designed specifically for transduction
of blood flow velocity signals from within the head. Because the ultrasound energy must
transverse bone, a significant impediment to ultrasound, TCD systems typically utilize much
higher transmitted energy levels (adjustable) than cardiovascular systems.
Transducer (ultrasound) - A piezoelectric crystal (rigid) or polymer (flexible) capable of
converting sound energy to electrical energy and vice versa. Transducers for medical
applications typically operate in the 1 - 20 MHz band of frequencies and can be placed in
a variety of configurations for non-invasive, intracavity, intraluminal, or tramluminal
applications.
Ultrasound - Pressure variations at a frequency well above the range of hearing. In medical
applications, frequencies generally range from 1 to 20 MHz. Energy levels generally do not
exceed 50 mW/cm 2.
Venous circulation - The blood vessels which carry blood toward the heart. This may be
either deoxygenated blood (from the body tissues via the Vena Cava) or oxygenated blood
(from the lungs via the Pulmonary Vein). Normal pressures range from -5 to 10 mmHg.
The venous circulation is most susceptible to decompression air emboli.

APPENDIX C
Reouest to Industry

LSR
INCORPORATED
October 16, 1991
Dear Sir or Madam:
LSR is conducting a survey of organizations for NASA and GE
Government Services to determine potential concepts and manufacturers of
a customized medical ultrasound device for measurement of air emboli. The
device is described in the following pages.
Your organization's response is very important to us. We wish to
identify all interested parties. Please note the due dates on the 3 items listed
on the next page. Your timely response will insure that your organization is
represented in our final report to NASA/GE.
If you do not plan to participate, would you please so indicate by
checking the box at the bottom of the Questionnaire and returning it to me?
Thank you for taking the time to respond to this request. If you need
additional information, please do not hesitate to call either me at 505-262-
7749 or Dick Greene, Phl), at 505-262-7155. We will be glad to help.
Yours sincerely,
Jerry G. Davis
Vice-President
2441 Ridgecrest, S.E.
Albuquerque, New Mexico 87108
(505) 262-7749
Fax: (505) 262-7616
A Subsidiary of The Lovelace Medical Foundation
"In-Suit Ultrasonic Bubble Detector for EVA"
BACKGROUND INFQRMATION and INSTRUCTIONS
Astronauts often perform tasks which require Extravehicular Activity (EVA). During an
EVA, an astronaut wears a space suit which maintains an internal pressure of only 4 to 5 psia in
order to maximize suit flexibility. At this reduced pressure, the potential for formation and
circulation of gas microbubbles in the astronaut's bloodstream is a concern. In its early stages, this
phenomenon is sometimes associated with joint discomfort or pain (commonly called "the bends").
Although never observed in the limited number of EVAs by NASA astronauts, circulating
microbubbles have the potential for serious clinical sequelae.
Based on research experience, NASA is considering the development of a battery-powered,
ultrasound-based system which can be worn by an astronaut inside a space suit and can
continuously monitor bubble activity in the astronaut's blood. Under contract to NASA/GE
Government Services, LSR is performing a survey to identify potential methodologies and
manufacturers of such a custom system. The present LSR effort does not contain funding for a
development program.
We are requesting three (3) items from you:
1. Completed Questionnaire - Due Oct. 25. 1991. Included with this package is a
questionnaire which will help us develop a more thorough description of your company. Please
answer the questions as accurately as possible and include additional explanatory text, if necessary.
2. Corporate/Product Description - I)¢¢ Qct. 25. 1991. Please send a set of
sales/marketing literature which describes your organization's products, capabilities, and experience.
3. Description of Technical Approach - Due Nov. 1. 1991. Also accompanying this
document is a brief description of the "requirements" for the system. We would like for you to give
us a response to the stated requirements, realizing that the system is still in its conceptual stage.
We are not requesting a detailed proposal, but rather a short document (a "white paper") which
describes your approach to this system and addresses the major technological issues of this task.
Also, include a [ough-order-of-mamtitude price to develop an operational breadboard of the system.
""*** Do not include any proprietary or confidential information. *****
Mail to: Jerry G. Davis, VP
LSR, Inc.
2441 Ridgecrest, SE
Albuquerque, NM 87108
Phone: 505-262-7749
FAX: 505-262-7616
- REQUIREMENT_
This document is a broad definition of a small, battery-powered, ultrasound-based
instrument capable of monitoring micron-sized bubble activity in the pulmonary artery
bloodflow of an astronaut in a space suit. Other monitoring sites may also be considered.
Once configured, the instrument must operate unattended during Extravehicular Activity.
In one potential configuration, the system would consist of a low-profile transducer located
on the astronaut's chest (worn under a cooling garment made of a "spandex-Uke" material
with imbedded tubing for circulating water). All processing electronics would also be located
inside the space suit. The output signal(s) may either be recorded on a small recording de-
vice/module mounted inside the space suit or telemetered from the space suit.
A concept utilizing a multiple-crystal transducer is shown in simplified form on the attached
drawing. This concept could potentially track a moving vessel. However, this is representa-
tive only, and any/all other approaches are welcome and encouraged.
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Transducer-to-Site Interface: self-attaching/adhering. Stable and continuously
operable without operator manipulation after initial attachment.
Artifact Rejection: Capable of continuously monitoring bubble activity with little
artifact during slow upper body movements.
Dynamic Range: Sufficient dynamic range to detect and record bubble echoes
without saturation or distortion.
Transducer Size: Low profile, comfortably worn under the cooling garment.
Power: Battery-powered, minimum 6 hour capacity
Weight: Breadboard < 3 lb
(Flight model weight less than 0.5 lb)
Volume: Breadboard < 50 in s
(Flight model volume less than 5 ins
Operating temperature: 60 - 100 "F (15 - 38 "C)
9. Operating atmosphere: 100% O2 @ 4 psia
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Your name:
Your organization:
OUESTIONNAIRE
Telephone #:
II
2.
How many years has your organization been in the ultrasound marketplace?
How many cumulative engineering person-years of experience does your current staff have
in design of medical ultrasound equipment?
1 Does your organization have experience in design of battery-operated, medical, ultrasound
equipment (Y/N)? If yes, approximately how many cumulative engineering person-
years?
. Does your organization have experience in design of flight equipment (Y/N)?
If yes, please explain:
. Does your organization have experience in design of ultrasound equipment specifically for
circulating microbubble detection (Y/N)? If yes, please explain:
o What are your organization's unique strengths in the design of ultrasound equipment?
1 What patents or intellectual property does your organization hold which could be relevant
to this project?
1 Will your organization be submitting a "Description of Technical Approach" by Friday,
November 1, 1991 (Y/N)?
_] My organization chooses not to submit a response to this request.
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Sample Database Search

SEARCH TERMS: embolism.mj, and ultrasonography.mj, and air
--> 21 DOCUMENTS FOUND
1
R021 Links Available
AN 91165125. 91063.
AU Russell-D. Madden-K-P. Clark-W-M. Sandset-P-M. Zivin-J-A.
IN Department of Neurosciences, University of California, San Diego, La
Jolla.
TI Detection of arterial emboli using Doppler ultrasound in rabbits.
SO Stroke. 1991 Feb. 22(2). P 253-8.
JT STROKE.
PT JOURNAL ARTICLE (ART).
LG English (EN).
AB The purpose of this study was to develop an animal model that could
be used to test the ability of Doppler ultrasound to detect arterial
emboli composed of materials that are often involved in cerebral
emboli. Emboli introduced into the rabbit aorta via the left renal
artery consisted of clotted whole blood, platelets, atheromatous
material, fat, or *air.* The ultrasound examination was carried out
continuously during the studies using a multifrequency transcranial
Doppler apparatus with a 2-MHz probe, a sample volume of 15 mm, at a
depth of 15 mm. The intensity of the Doppler spectrum was measured
and displayed as a 15-shade color scale, each shade representing a
3-dB difference. The diameter of the aorta at the site of the
ultrasound examination was similar to the diameter of the middle
cerebral artery in humans. All 125 emboli introduced were clearly
detected because they caused a Doppler signal at least 15 dB greater
than that of the surrounding blood. These results show that the
potential for emboli detection using Doppler ultrasound in the
clinical situation is now considerable. Author-abstract.
MJ *CEREBRAL-EMBOLISM-AND-THROMBOSIS:* *ultrasonography* (us).
MN ANIMAL. BLOOD-FLOW-VELOCITY. *CEREBRAL-EMBOLISM-AND-THROMBOSIS:*
physiopathology (pp). CEREBROVASCULAR-CIRCULATION. HUMAN. RABBITS.
SUPPORT-NON-U-S-GOVT. SUPPORT-U-S-GOVT-P-H-S.
SB Priority Journals (M).
YR 1991.
IS 0039-2499. V2J.
CP UNITED-STATES (ZI.I07.567.875).
IM 9106.
ND ENTRY DATE: 910418.
NO NS23814.
2
AN 91138424. 91055.
AU Marcus-R-H. Weinert-L. Neumann-A. Borow-K-M. Lang-R-M.
IN Department of Medicine, University of Chicago Medical Center 60637.
TI Venous *air* *embolism.* Diagnosis by spontaneous right-sided contrast
echocardiography.
SO Chest. 1991 Mar. 99(3). P 784-5.
JT CHEST.
PTJOURNALARTICLE (ART).
LG English (EN).
AB This report describes the definitive diagnosis of venous *air-embolism*
by documentation of spontaneous echo contrast in the right cardiac
chambers following removal of a jugular venous catheter in a patient
with hepatic failure. This complication was potentiated by the
presence of concurrent hepatic coagulopathy which prejudiced
effective hemostasis at the central venous puncture site.
Author-abstract.
MJ ECHOCARDIOGRAPHY. *EMBOLISM-AIR:* *ultrasonography* (us).
MN CASE-REPORT. CATHETERIZATION-CENTRAL-VENOUS: adverse-effects (ae).
FEMALE. HUMAN. JUGULAR-VEINS. MIDDLE-AGE.
SB Abridged Index Medicus Journals (A). Priority Journals (M).
Journals (X).
YR 1991.
IS 0012-3692. DIC.
CP UNITED-STATES (ZI.I07.567.875).
IM 9105.
ND ENTRY DATE: 910328.
Cancer
3
AN 91122522. 91053.
AU Bodewes-H-W. Puylaert-J-B.
IN Department of Radiology, Westeinde Hospital, The Hague, The
Netherlands.
TI Ultrasound in detection of portal venous gas in adults.
SO Gastrointest-Radiol. 1991 Winter. 16(1). P 35-7.
JT GASTROINTESTINAL RADIOLOGY.
PT JOURNAL ARTICLE (ART).
LG English (EN).
AB Three patients with sonographically demonstrated portal venous gas
are presented. Two patients were also studied using computed
tomography (CT). Both techniques had superior sensitivity compared
to plain radiographs. Scattered echogenic patches in the liver
parenchyma, and centrifugal flow of echogenic patches in the portal
vein and its branches, are typical ultrasound findings of portal vein
gas. Evaluation of ultrasound findings and coordination with
clinical history differentiate portal vein gas from biliary gas.
Author-abstract.
MJ *EMBOLISM-AIR:* *ultrasonography* (us). PORTAL-VEIN: *ultrasonography*-
(us).
MN AGED. AGED-80-AND-OVER. CASE-REPORT. *EMBOLISM-AIR:* radiography
(ra). FEMALE. HUMAN. LIVER: *ultrasonography* (us). PORTAL-VEIN:
radiography (ra). TOMOGRAPHY-X-RAY-COMPUTED.
SB Priority Journals (M).
YR 1991.
IS 0364-2356. FGZ.
CP UNITED-STATES (ZI.i07.567.875).
IM 9105.
ND ENTRY DATE: 910308.
4
AN 91121831. 91053.
AU Clayton-R-H. Pearson-D-T. Murray-A.
IN Regional Medical Physics Department, Freeman Hospital, Newcastle upon
Tyne, UK.
TI Clinical comparison of two devices for detection of microemboli
during cardiopulmonary bypass.
SO Clin-Phys-Physiol-Meas. 1990 Nov. 11(4). P 327-32.
JT CLINICAL PHYSICS AND PHYSIOLOGICAL MEASUREMENT.
PT JOURNAL ARTICLE (ART).
LG English (EN).
AB Detection of gaseous microemboli during cardiopulmonary bypass
procedures is important for the clinical evaluation of equipment such
as oxygenators and cardiotomy reservoirs. Comparison of published
data can be difficult if different detectors are used. Two devices
reported in the literature, the Technique Laboratories TM-8 and the
Hatteland BD-100, are compared during clinical procedures. The
relationship between the outputs of these devices was linear over two
ranges, the difference in output amounted to a standard deviation of
11% in the lower range and 38% in the upper range. Author-abstract.
MJ CARDIOPULMONARY-BYPASS. *EMBOLISM-AIR:* *ultrasonography* (us).
MN COMPARATIVE-STUDY. *EMBOLISM-AIR:* etiology (et). HUMAN.
OXYGENATORS. SUPPORT-NON-U-S-GOVT. *ULTRASONOGRAPHY:* instrumentation
(is).
SB Priority Journals (M).
YR 1990.
IS 0143-0815. DKB.
CP ENGLAND (ZI.542.363.300).
IM 9105.
ND ENTRY DATE: 910314.
5
R021 Links Available
AN 91112878. 91051.
AU van-der-Linden-J. Casimir-Ahn-H.
IN Department of Anesthesia and Intensive Care, University Hospital,
Uppsala, Sweden.
TI When do cerebral emboli appear during open heart operations? A
transcranial Doppler study.
SO Ann-Thorac-Surg. 1991 Feb. 51(2). P 237-41.
JT ANNALS OF THORACIC SURGERY.
PT JOURNAL ARTICLE (ART).
LG English (EN).
AB The transcranial Doppler technique enabled the detection of cerebral
*air* emboli in i0 of i0 patients during open-heart valve operations
despite standard deairing procedures. With this technique, the
occurrence of emboli in the right middle cerebral artery was followed
continuously in patients undergoing aortic or mitral valve
replacement. Membrane oxygenators were used. Scattered emboli were
observed during the insertion of the aortic cannula, at the start of
cardiopulmonary bypass, and after the declamping of the aorta with
the heart beating while empty. During the period of aortic
cross-clamping, no emboli were detected. Despite careful deairing
procedures, the recordings indicated a large amount of emboli during
filling of the empty beating heart in all i0 patients. Thus, this
study indicates that cerebral emboli in open heart procedures are
most likely to occur during the redistribution of blood from the
heart-lung machine to the patient when the heart is beginning to
eject actively, despite careful standard deairing procedures.
Meticulous deairing before declamping the aorta is strongly
advocated. In addition, a short period of filling of the beating
heart before final closure of the aortic incision or vent may
decrease the incidence of cerebral emboli. A concomitant reduction
in cerebral blood flow by hyperventilation or anesthetics or both
during filling of the empty beating heart may also be beneficial.
Author-abstract.
MJ *CEREBRAL-EMBOLISM-AND-THROMBOSIS:* *ultrasonography* (us).
*EMBOLISM-AIR:* *ultrasonography* (us). HEART-SURGERY: adverse-effects
(ae) .
MN AORTIC-VALVE: surgery (su). CEREBRAL-ANGIOGRAPHY.
*CEREBRAL-EMBOLISM-AND-THROMBOSIS:* etiology (et), radiography (ra).
*EMBOLISM-AIR:* etiology (et), radiography (ra). HUMAN. MITRAL-VALVE:
surgery (su). MONITORING-PHYSIOLOGIC. SUPPORT-NON-U-S-GOVT.
TIME-FACTORS. TOMOGRAPHY-X-RAY-COMPUTED.
SB Abridged Index Medicus Journals (A). Priority Journals (M).
YR 1991.
IS 0003-4975. 683.
CP UNITED-STATES (ZI.I07.567.875).
IM 9105.
ND ENTRY DATE: 910228.
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R021 Links Available
AN 91023531. 91011.
AU Losasso-T-J. Muzzi-D-A. Cucchiara-R-F.
TI Doppler detection of intravenous mannitol crystals mimics venous *air*
*embolism* 'letter:.
SO Anesth-Analg. 1990 Nov. 71(5). P 568-9.
JT ANESTHESIA AND ANALGESIA.
PT LETTER (LET).
LG English (EN).
MJ *EMBOLISM-AIR:* *ultrasonography* (us). MANNITOL: blood (bl).
MN AGED. CASE-REPORT. CRANIOTOMY. CRYSTALLIZATION. HUMAN.
INTRAOPERATIVE-COMPLICATIONS. MALE.
RN 87-78-5 -- Mannitol.
SB Abridged Index Medicus Journals (A).
YR 1990.
IS 0003-2999. 4R8.
CP UNITED-STATES (ZI.I07.567.875).
IM 9101.
ND ENTRY DATE: 901119.
Priority Journals (M).
VEINS. _
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AN 90247232. 90000.
AU Kriegshauser-J-S. Reading-C-C. King-B-F. Welch-T-J.
IN Department of Diagnostic Radiology, Mayo Clinic, Rochester, MN 55905. --
TI Combined systemic and portal venous gas: sonographic and CT detection
in two cases.
SO AJR-Am-J-Roentgenol. 1990 Jun. 154(6). P 1219-21.
JT AJR. AMERICAN JOURNAL OF ROENTGENOLOGY.
LG English (EN).
MJ *EMBOLISM-AIR:* diagnosis (di). PORTAL-VEIN.
TOMOGRAPHY-X-RAY-COMPUTED. *ULTRASONOGRAPHY.*
MN ABDOMINAL-NEOPLASMS: complications (co). AGED. CASE-REPORT.
*EMBOLISM-AIR:* etiology (et). HEPATIC-VEINS. HUMAN. INTESTINES:
blood-supply (bs). ISCHEMIA: complications (co). MALE. MESENTERY: --
surgery (su). MIDDLE-AGE.
SB Abridged Index Medicus Journals (A).
Journals (X).
YR 1990.
IS 3AE.
CP UNITED-STATES (ZI.I07.567.875).
IM 9008.
ND ENTRY DATE: 900613.
CLASS UPDATE: 90.
Priority Journals (M). Cancer
8
AN 90182806. 90000.
AU Fong-J. Gadalla-F. Gimbel-A-A.
IN Department of Anesthesiology, New York Hospital, NY 10021.
TI Precordial Doppler diagnosis of haemodynamically compromising *air*
*embolism* during caesarean section.
SO Can-J-Anaesth. 1990 Mar. 37(2). P 262-4.
JT CANADIAN JOURNAL OF ANAESTHESIA.
LG English (EN).
AB This is a report of a 39-year-old parturient who had a
haemodynamically compromising venous *air* *embolism* during a repeat
Caesarean section under lumbar epidural anaesthesia. The *embolism*
occurred immediately after surgical incision during surgery in the
superficial subcutaneous tissues. The diagnosis was made using
intraoperative precordial ultrasonic Doppler monitoring which allowed
early and successful treatment. Author-abstract.
MJ CESAREAN-SECTION: adverse-effects (ae). *EMBOLISM-AIR:* etiology (et).
INTRAOPERATIVE-COMPLICATIONS: diagnosis (di). *ULTRASONOGRAPHY.*
MN ADULT. CASE-REPORT. *EMBOLISM-AIR:* diagnosis (di). FEMALE. HUMAN.
LABOR-COMPLICATIONS. MONITORING-PHYSIOLOGIC. PRE(GNANCY.
SB Priority Journals (M).
YR 1990.
IS 0832-610X. C8L.
CP CANADA (Zi.i07.567.176).
IM 9006.
ND ENTRY DATE: 900420.
CLASS UPDATE: 90.
9
AN 90176840. 90000.
AU Spencer-M-P. Thomas-G-I. Nicholls-S-C. Sauvage-L-R.
IN Providence Medical Center, Seattle, Washington.
TI Detection of middle cerebral artery emboli during carotid
endarterectomy using transcranial Doppler *ultrasonography.*
SO Stroke. 1990 Mar. 21(3). P 415-23.
JT STROKE.
LG English (EN).
AB The purpose of our study was to define the signal characteristics and
clinical circumstances associated with emboli detected in the middle
cerebral artery using 2-MHz pulsed transcranial Doppler ultrasound in
patients undergoing carotid endarterectomy. Signals designating
emboli were transients displaying harmonic qualities the signatures
of which were clearly different from those of mechanical and
electronic artifacts. We reviewed the audio/video tape recordings
from 91 patients for signals of *air* bubble emboli occurring upon
release of common carotid artery crossclamps; recordings from 35
patients (38%) demonstrated *air* bubble emboli. Transients with
signatures identical to those of *air* bubble emboli were also
discovered when bubbles in the bloodstream were improbable; we
defined these transients as representing formed-element emboli. Such
signals were found in recordings from 24 patients (26%), and they
occurred before (both spontaneously and upon common carotid artery
compression), during, and after surgical dissection. Signals
indicating formed-element emboli were associated with intraluminal
platelet thrombus, with ulcerations in the carotid artery, and with
transient ischemic attacks or stroke. Most postoperative
formed-element emboli did not cause symptoms but, when persisting for
hours, they were associated with strokes and cerebral infarction.
This Doppler ultrasound method of detecting emboli will be useful in
the study of stroke mechanisms and as a clinical test to guide the
medical and surgical treatment of patients at risk of stroke.
Author-abstract.
MJ CAROTID-ARTERIES: surgery (su). *CEREBRAL-EMBOLISM-AND-THROMBOSIS:*
diagnosis (di). *EMBOLISM-AIR:* diagnosis (di). ENDARTERECTOMY.
*ULTRASONOGRAPHY.*
MN ARTERIAL-OCCLUSIVE-DISEASES: surgery (su). BLINDNESS: etiology (et).
CAROTID-ARTERY-DISEASES: surgery (su).
,CEREBRAL-EMBOLISM-AND-THROMBOSIS:* etiology (et). *EMBOLISM-AIR:*
etiology (et). ENDARTERECTOMY: adverse-effects (ae). HUMAN.
INTRAOPERATIVE-COMPLICATIONS. SKULL. SUPPORT-NON-U-S-GOVT.
*ULTRASONOGRAPHY:* methods (mt).
SB Priority Journals (M).
YR 1990.
IS 0039-2499. V2J.
CP UNITED-STATES (Zi.i07.567.875).
IM 9006.
ND ENTRY DATE: 900411.
CLASS UPDATE: 90.
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AN 90166772. 90000.
AU Deverall-P-B. Padayachee-T-S. Parsons-S. Theobold-R.
Battistessa-S-A.
IN Department of Cardiothoracic Surgery, Guy's Hospital, London, UK.
TI Ultrasound detection of micro-emboli in the middle cerebral artery
during cardiopulmonary bypass surgery.
SO Eur-J-Cardiothorac-Surg. 1988. 2(4). P 256-60.
JT EUROPEAN JOURNAL OF CARDIO-THORACIC SURGERY.
LG English (EN).
AB The occurrence of neurological sequelae following cardiopulmonary
bypass (CBP) surgery has stimulated interest in refining the
techniques of extracorporeal circulation. *Air* micro-emboli
originating from the oxygenator have been postulated as one source of --
cerebral damage. Since controversy still exists regarding the merits
of bubble versus membrane oxygenators, this has prompted
investigators to devise methods to determine the amount of
micro-emboli produced during CPB. In this study, 27 patients
undergoing CPB surgery for coronary artery disease (21) or valve
replacement (6) were examined. The surgical and anaesthetic
techniques were standardised in all patients except for the type of
oxygenator used. A bubble oxygenator was used in 17 patients
(Bentley Bio-10, William Harvey or Dideco) and a membrane oxygenator
with a 25 microns filter in the remaining 10 patients (Bentley BOS
CM50). Transcranial pulsed Doppler ultrasound was used to obtain
blood velocity signals from the middle cerebral artery throughout
CPB. A flow disturbance index (FDI) was defined which provided a
representative index of the number of micro-emboli passing the
ultrasound transducer. The FDI indicated the presence of gaseous
micro-emboli during insertion of the aortic cannula in 22 of the 27
patients. In the 17 patients with a bubble oxygenator, the FDI
ranged from 4-39. In the I0 patients with a membrane oxygenator, the
FDI was always 0. Variation of gas flow rates in 3 patients with
bubble oxygenators showed a change in the FDI from 4 +/- 4 at a flow --
rate of 2 i/min to 17 +/- 9 at 5 I/min.(ABSTRACT TRUNCATED AT 250
WORDS). Author-abstract.
MJ CARDIOPULMONARY-BYPASS: adverse-effects (ae).
*CEREBRAL-EMBOLISM-AND-THROMBOSIS:* diagnosis (di). *EMBOLISM-AIR:*
diagnosis (di). OXYGENATORS: adverse-effects (ae). *ULTRASONOGRAPHY._
MN ADULT. CEREBRAL-ARTERIES: physiopathology (pp).
*CEREBRAL-EMBOLISM-AND-THROMBOSIS:* etiology (et). *EMBOLISM-AIR:*
etiology (et). HUMAN. INTRAOPERATIVE-PERIOD. MIDDLE-AGE. OXYGEN:
blood (bl). REGIONAL-BLOOD-FLOW.
RN 7782-44-7 -- Oxygen.
SB Priority Journals (M).
YR 1988.
IS 1010-7940. AOJ.
CP GERMANY-WEST (Z1.542.315.570).
IM 9006.
ND ENTRY DATE: 900411.
CLASS UPDATE: 90.
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AN 90120067. 90000.
AU Muzzi-D-A. Losasso-T-J. Black-S. Nishimura-R.
IN Department of Anesthesiology, Mayo Medical School, Rochester,
Minnesota.
TI Comparison of a transesophageal and precordial ultrasonic Doppler
sensor in the detection of venous *air* *embolism.*
SO Anesth-Analg. 1990 Jan. 70(1). P 103-4.
JT ANESTHESIA AND ANALGESIA.
LG English (EN).
MJ *EMBOLISM-AIR:* diagnosis (di). *ULTRASONOGRAPHY.*
MN COMPARATIVE-STUDY. ECHOCARDIOGRAPHY-DOPPLER. ESOPHAGUS. HUMAN.
SB Abridged Index Medicus Journals (A). Priority Journals (M).
YR 1990.
IS 0003-2999. 4R8.
CP UNITED-STATES (Z1.107.567.875).
IM 9004.
ND ENTRY DATE: 900221.
CLASS UPDATE: 90.
12
AN 89287930. 89000.
AU McFadden-S. Dunlop-W-E.
IN Department of Surgery, Calgary General Hospital, Alta.
TI Hepatic portal venous gas in adults: importance of *ultrasonography* in
early diagnosis and survival.
SO Can-J-Surg. 1989 Jul. 32(4). P 297-8.
JT CANADIAN JOURNAL OF SURGERY.
LG English (EN).
AB Hepatic portal venous gas (HPVG) is an ominous radiologic sign and
indicates the need for urgent surgical intervention. The causes are
varied, but the commonest and most serious is infarcted bowel.
Because HPVG is difficult to detect on plain abdominal x-ray films,
more reliable methods have been sought. The authors describe the
case of a 31-year-old man to illustrate the need for and benefit of
early detection of HPVG using *ultrasonography,* which was instrumental
in the survival of the patient. Author-abstract.
MJ *EMBOLISM-AIR:* diagnosis (di). PORTAL-VEIN. *ULTRASONOGRAPH¥.*
MN ADULT. CASE-REPORT. EVALUATION-STUDIES. HUMAN. MALE.
TIME-FACTORS.
SB Priority Journals (M).
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AU Padayachee-T-S. Parsons-S. Theobold-R. Gosling-R-G. Deverall-P-B.
IN Department of Radiological Sciences, Guy's Hospital, London, England.
TI The effect of arterial filtration on reduction of gaseous microemboli
in the middle cerebral artery during cardiopulmonary bypass.
SO Ann-Thorac-Surg. 1988 Jun. 45(6). P 647-9.
JT ANNALS OF THORACIC SURGERY.
LG English (EN).
AB Noninvasive in vivo detection of gaseous microemboli in the middle
cerebral artery, by transcranial Doppler ultrasound, was used to
determine the effect of filtration in the arterial catheter using 25-
and 40-microns filters and bubble oxygenators in patients undergoing
cardiopulmonary bypass surgery. Eighteen patients undergoing
coronary artery bypass surgery were studied using a closed cardiac
(unvented heart) model. Group 1 patients (no filters) had the
highest incidence of gaseous microemboli, as indicated by the
ultrasound microemboli index, at both high and low oxygen flow rates.
Group 2 patients (40-microns filters) had a significantly lower
microemboli index, particularly at low oxygen flow rates (t = 4.9, p _
less than 0.001). The 25-microns group patients had the lowest
values of all. No microemboli were detected at low oxygen flow
rates, and microemboli were detected in only 0.1% of the samples at
high oxygen flow rates. Additionally, observations on vented hearts --
in 3 patients undergoing cardiac valve surgery indicate that the
origin of gaseous microemboli may be *air* trapped inside the heart.
Author-abstract.
MJ CARDIOPULMONARY-BYPASS. *CEREBRAL-EMBOLISM-AND-THROMBOSIS:*
prevention-and-control (pc). *EMBOLISM-AIR:* prevention-and-control
(pc). FILTRATION: instrumentation (is). OXYGENATORS.
*ULTRASONOGRAPHY.*
MNCEREBRAL-ARTERIES: pathology (pa). *CEREBRAL-EMBOLISM-AND-THROMBOSIS:*
diagnosis (di). COMPARATIVE-STUDY. *EMBOLISM-AIR:* diagnosis (di).
HUMAN. INTRAOPERATIVE-CARE: methods (mt).
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AU Gibby-G-L.
TI Precordial Doppler is not obsolete for venous *air* *embolism* monitoring
_letter:.
SO Anesthesiology. 1988 May. 68(5). P 829.
JT ANESTHESIOLOGY.
LG English (EN).
MJ *EMBOLISM-AIR:* diagnosis (di). MONITORING-PHYSIOLOGIC:
instrumentation (is). *ULTRASONOGRAPHY:* instrumentation (is). VEINST
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AU Robberecht-E-A. Afschrift-M. De-BeI-C-E. Van-Haesebrouck-P-J.
Van-Bever-H-P. De-Wit-M. Leroy-J-G.
IN Children's Hospital C. Hooft, Ghent, Belgium.
TI Sonographic demonstration of portal venous gas in necrotizing
enterocolitis.
SO Eur-J-Pediatr. 1988 Feb. 147(2). P 192-4.
JT EUROPEAN JOURNAL OF PEDIATRICS.
LG English (EN).
AB Portal vein gas *embolism* was demonstrated by ultrasound in a preterm
infant with necrotizing enterocolitis. This sign could not be
detected radiographically. It is speculated that portal venous gas
occurs more frequently than hitherto inferred from radiological
studies. This observation points to the value of *ultrasonography* in
providing early objective evidence in support of the diagnosis of
NEC. The favourable outcome for the patient proves that portal
venous gas *embolism* is not necessarily associated with a fulminant
course of enterocolitis. Author-abstract.
MJ *EMBOLISM-AIR:* diagnosis (di). ENTEROCOLITIS-PSEUDOMEMBRANOUS:
diagnosis (di). PORTAL-VEIN: pathology (pa). *ULTRASONOGRAPHY.*
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AU Gibby-G-L. Ghani-G-A.
IN Department of Anesthesiology, University of Florida College of
Medicine, Gainesville.
TI Computer-assisted Doppler monitoring to enhance detection of *air*
emboli.
SO J-Clin-Monit. 1988 Jan. 4(1). P 64-73.
JT JOURNAL OF CLINICAL MONITORING.
LG English (EN).
AB Currently, two of the most sensitive clinical approaches commonly
used to monitor for venous *air* *embolism,* i.e., precordial Doppler
audio and capnography, require the attention of the
anesthesiologist's eye or ear, which is a distraction from other
aspects of care. To assess the feasibility of allowing the computer
to relieve the necessity for continuous human monitoring, we
developed a computer algorithm for monitoring the precordial Doppler
audio. This algorithm extracted (1) the amplitude of certain
higher-frequency components of the Doppler audio, (2) a measure of
the average value of the envelope of Doppler audio, and (3) the ratio
between the average value of the Doppler envelope and the amount of
envelope signal variation at heart rate frequency and its multiples.
These three features were monitored by an adaptive pattern
recognition algorithm that compared each new value for each feature
with the previously developed mean and standard deviation for that
feature. If the changes in the three features exceeded a detection
threshold, an alarm (indicating suspected *air* *embolism)* was
activated. Implemented as a prototype system, the algorithm was
given preliminary testing in 2 dogs and activated alarms at levels of
*air* well below those reported to cause clinically significant
hemodynamic changes in dogs. While decreasing the distraction for
the anesthesiologist, this early prototype alarm system alerts its
user to the need for analysis of the Doppler signals when it senses
an *air* embolus. Author-abstract.
MJ ALGORITHMS. *EMBOLISM-AIR:* diagnosis (di). MONITORING-PHYSIOLOGIC:
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methods (mt).
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AU Malinow-A-M. Naulty-J-S. Hunt-C-O. Datta-S. Ostheimer-G-W.
IN Department of Anaesthesia, Brigham and Women's Hospital, Harvard
Medical School, Boston, Massachusetts.
TI Precordial ultrasonic monitoring during cesarean delivery.
SO Anesthesiology. 1987 Jun. 66(6). P 816-9.
JT ANESTHESIOLOGY.
LG English (EN).
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AU Grant-J. Murphy-J-F.
TI Pulsed Doppler diagnosis of cerebral *air* embolus in a baby with
pulmonary interstitial emphysema _letter:.
SO Lancet. 1986 Oct 25. 2(8513). P 983-4.
JT LANCET.
LG English (EN).
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AU Azad-S-S. Maguire-D. Goldberg-M-E.
IN Department of Anesthesiology, Jefferson Medical College of Thomas
Jefferson University, Philadelphia, Pennsylvania.
TI Junctional rhythm can mimic *air* *embolism* during precordial Dopplez_
monitoring _published erratum appears in Anesth Analog 1987
Jan;66(1):100:.
SO Anesth-Analg. 1986 Oct. 65(10). P 1083-4.
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HUMAN. MALE.
Priority Journals (M).
20
AN 86132259. 86000.
AU Fataar-S. Cadogan-E. Spruyt-O.
IN Department of Radiology, Green Lane Hospital, Auckland, New Zealand.
TI *Ultrasonography* of hepatic portal venous gas due to diverticulitis.
SO Br-J-Radiol. 1986 Feb. 59(698). P 183-5.
JT BRITISH JOURNAL OF RADIOLOGY.
LG English (EN).
MJ DIVERTICULITIS-COLONIC: complications (co).
(di). PORTAL-VEIN. *ULTRASONOGRAPHY.*
MN CASE-REPORT. *EMBOLISM-AIR:* etiology (et).
blood-supply (bs). MALE. MIDDLE-AGE.
SB Abridged Index Medicus Journals (A).
Journals (X).
YR 1986.
IS 0007-1285. B28.
CP ENGLAND (ZI.542.363.300).
IM 8606.
ND ENTRY DATE: 860404.
CLASS UPDATE: 90.
*EMBOLISM-AIR:* diagnosis
HUMAN. LIVER:
Priority Journals (M). Cancer
21
AN 86129036. 86000.
AU Porcel-A. Taboury-J. Aboulker-C. Berrod-J-L. Tubiana-J-M.
TI *'Air* in the portal system and mesenteric infarction. Value of
ultrasonic examination. Apropos of a case:.
TT Aeroportie et infarctus mesenterique. Interet de l'examen
echographique. Apropos d'une observation.
SO Ann-Radiol (Paris). 1985. 28(8). P 615-7.
JT ANNALES DE RADIOLOGIE.
LG French (FR).
MJ *EMBOLISM-AIR:* etiology (et). INFARCTION: complications (co).
INTESTINE-SMALL: blood-supply (bs). PORTAL-SYSTEM: pathology (pa).
*ULTRASONOGRAPHY.*
MN ADULT. CASE-REPORT. *EMBOLISM-AIR:* diagnosis (di).
ENGLISH-ABSTRACT. HUMAN. MALE.
YR 1985.
IS 0003-4185. 5W6.
CP FRANCE (ZI.542.286).
IM 8605.
ND ENTRY DATE: 860318.
CLASS UPDATE: 90.
END OF DOCUMENTS IN LIST

APPENDIX E
List of Ultrasound Manufacturing/R&D Organizations

- Ultrasound Equipment Manufacturers
Company Name:
Address:
Area(s) of expertise:
Contact Person:
Phone:
FAX:
Notes:
Acoustic Imaging Technologies
10027 S. 51st St.
Phoenix, AZ 85004
Duplex scanners
Kerr Spencer
602-496-6681
602-496-6679
(602-820-3187 old #?)
Owned by Dornier Medical Systems
Company Name:
Address:
Area(s) of expertise:
# employees:
# yrs in business:
$ annual sales:
Contact Person:
Phone:
FAX:
Acuson, Inc.
1220 Charleston St.
P.O. Box 7393
Mountain View, CA 94O39
Duplex scanners
1,000
11
$227M
Ron Bucheger, VP Mktg.
415-969-9112
415-964-8331
Company Name:
Address:
Area(s) of expertise:
# employees:
# yrs in business:
$ annual sales:
Contact Person:
Phone:
FAX:
Advanced Medical Devices, Inc.
2733 Saunders Street
Camden, NJ 08105
Transducers
20
5
$1 M
Mark Orvak, Pres.
609-964-8448
609-365-8065
Company Name:
Address:
Advanced Medical Systems
925 Sherman Ave.
Hamden, CT 06514
# of employees:
# yrs in business:
$ annual sales:
Contact Person:
Phone:
FAX:
45
$4.5 M
800-325-2070
203-288-9032
203-245-0500
Company Name:
Address:
Area(s) of expertise:
# employees:
# yrs in business:
$ annual sales:
Contact Person:
Phone:
FAX:
Notes:
Advanced Technology Laboratories
22100 Bothell Hwy. SE
P.O. Box 3003
Bothell, WA 98041
Duplex scanners
1,500
10 +
$365 M
Chuck Boyle, VP/product development
1-800-982-2011 206-487-7000
206485-3680
Owned by Westmark International
Company Name:
Address:
Area(s) of expertise:
# employees:
# yrs in business:
$ annual sales:
Contact Person:
Phone:
FAX:
Applied Biometrics, Inc.
6269 Bury Drive
Eden Prairie, MN 55346
Cardiac output with pulse doppler transducer at tip of transtracheal
tube
17
7
still in development of C.O. monitor
Chris Peterson, Engineering Manager
612-934-8849
612-934-8837
Company Name:
Address:
# employees:
# yrs in business:
$ annual sales:
Biomedicus, Inc.
9600 w. 76 th St.
Eden Prairie, MN
160
$41 M
55345
Contact Person:
Phone:
FAX:
James Lyons, Pres.
800-328-4434 612-944-7784
612-944-7557
Company Name:
Address:
# employees:
# yrs in business:
$ annual sales:
Contact Person:
Phone:
FAX:
Notes:
Biosound, Inc.
7990 Castleway Drive
Indianapolis, IN 46250
2OO
11
$50 M
Barbara Woff, Mgr./URrasound
800-428-4374 317-849-1793
317-841-8616
Owned by Esaote Biomedica
Company Name:
Address:
# employees:
# yrs in business:
$ annual sales:
Bruel & Kjaer Instruments, Inc.
185 Forest St.
Marlborough, MA 01752
215
15
$2O M
Contact Person:
Phone:
FAX:
Notes:
Ralph Winter, U.S. Mktg. Mgr.
800-876-7226 508-481-7000
508-485-0519
All R&D/manufacturing done in Denmark
Company Name:
Address:
Area(s) of expertise:
# employees:
# yrs in business:
$ annual sales:
Contact Person:
Phone:
FAX:
Carolina Medical Electronics, Inc.
157 Industrial Drive
P.O. Box 307
King, NC 27021
Electromagnetic flowmetry
45
3O
$3M
Richard Hager, Dir. Engr.
800-334-4531 919-983-5132
919-983-8992
Company Name:
Address:
# employees:
# yrs in business:
$ annual sales:
Contact Person:
Phone:
FAX:
Circadian, Inc.
3942 N. 1st St.
San Jose, CA 95134
180
$2 M
Ron Lou
800-669-7001 408-943-9222
408-434-9585
Company Name:
Address:
Area(s) of expertise:
# employees:
# yrs in business:
$ annual sales:
Contact Person:
Phone:
FAX:
Notes:
Corometrics Medical Systems, Inc.
61 Barnes Park Rd. N.
P.O. Box 333
Wallingford, CT 06492
Fetal ultrasound monitoring
7O0
Dan Boucher, VP
800-243-3952
203-284-9465
203-265-5631
Owned by American Home Products Corp.
Company Name:
Address:
# employees:
# yrs in business:
$ annual sales:
Contact Person:
Phone:
FAX:
Notes:
Crystal Biotech, Inc.
75 South St.
Hopkinton, MA 01748
6
4
Jane Hasson
800-325-5977
508-435-2165
508-435-9039
Invasive ultrasound - mostly for animal research
Company Name:
Address:
Area(s) of expertise:
DiagnosUc Ultrasound Corp.
P.O. Box 789
Kirkland, WA 98083
Urology/Portable bladder volume/flow
# employees:
# yrs in business:
$ annual sales:
Contact Person:
Phone:
FAX:
2O
7
Gerald McMorrow, Pres.
800-331-2313 206-828-3860
206-827-8324
Company Name:
Address:
Area(s) of expertise:
# employees:
# yrs in business:
$ annual sales:
Diasonics, Inc.
1565 Barber Lane
Milpitas, CA 95035
Duplex scanner
1,600
13
$280 a
Contact Person:
Phone:
FAX:
Notes:
Chris Bohl
800-421-1968
Owned by Toshiba Corp.
Company Name:
Address:
Area(s) of expertise:
# employees:
# yrs in business:
$ annual sales:
Contact Person:
Phone:
FAX:
Notes:
Dymax Corp.
604 Epsilon Drive
Pittsburgh, PA 15238
Ultrasound probes, annular probes (3D imaging)
26
10
$2 M
Phil Mattheis
412-963-6884
412-963-6179
Manufacturing, R&D in Norway
Company Name:
Address:
Eden Medical Electronics, Inc.
19226 66th Ave. South
Suite L103
Kent, WA 98032
Area(s) of expertise: Transcranial doppler, air-embolism detector
# employees:
# yrs in business:
$ annual sales:
Contact Person:
Phone:
FAX:
Notes:
>25
8
$2 M
John McCartney, VP/Engr.
800-323-3336 206-656-8330
408-980-9662
Owned by Eden Medical Electronics GMBH, TCD/NASA/shuttle
experience (Prof. Alec Eden - W. Germany)
Company Name:
Address:
# employees:
# yrs in business:
$ annual sales:
Contact Person:
Phone:
FAX:
Electro-Diagnostic Instruments
3401 Winona Ave.
Burbank, CA 91504
18
2O
$2 M
Bob Smith, Pres.
8O0-334-9944
818-843-0905
213-849-7701
Company Name:
Address:
Area(s) of expertise:
# employees:
# yrs in business:
$ annual sales:
Contact Person:
Phone:
FAX:
Notes:
Elscint, Inc.
P.O. Box 679
Boston, MA 02215
Ultrasonic (general purpose) scanner
2,400
8
$156 M
Doron Hess, Dir. Engr./Ultrasound
201-342-2020
201-342-3782
Owned by Elscint, Ltd., R&D/manufacturing facilities in Israel
Company Name:
Address:
Area(s) of expertise:
# employees:
# yrs in business:
$ annual sales:
EMS Medical, Inc.
302 Undbergh Ave.
Uvermore, CA 94550
Fetal ultrasound monitor
15
10
$2.5 i
Contact Person:
Phone:
FAX:
Paul Ulbrich, Pres.
415-449-3382
510-449-0887
Company Name:
Address:
Area(s) of expertise:
# employees:
# yrs in business:
$ annual sales:
Contact Person:
Phone:
FAX:
Notes:
GE Medical Systems
Box 414
Milwaukee, Wl 53201
Duplex scanners
9,200
Michael Ahlund
414-647-4404
414-544-3358
Multi-modality medical imaging company
Company Name:
Address:
Area(s) of expertise:
# employees:
# yrs in business:
$ annual sales:
Contact Person:
Phone:
FAX:
Notes:
Hewlett-Packard
3000 Minuteman Rd.
Andover, MA 01810
Duplex scanners
Mark Ringle
508-687-1501
508-689-9862
Formerly Ekoline ultrasound
Company Name:
Address:
Area(s) of expertise:
# employees:
# yrs in business:
$ annual sales:
Hoffrel Instruments, Inc.
345-A Wilson Ave.
P.O. Box 5825
South Norwalk, CT 06854
Custom transducers
12
28
$1 M
Contact Person: Russel Uphoff, Pres.
Phone:
FAX:
Notes:
203-866-9205
203-866-9207
Trasesophageal doppler for
neurosurgery
bubble detection (in heart) during-
Company Name:
Address:
Area(s) of expertise:
Contact Person:
Phone:
FAX:
Notes:
Craig Hartley, PhD
Baylor College of Medicine
Houston, TX
Currently building ultrasound imagers (20MHz) for small animals
Craig Hartley, PhD
713-798-4195
713-796-0015
Custom Research/Engineering lab
Company Name:
Address:
Area(s) of expertise:
# employees:
# yrs in business:
$ annual sales:
Contact Person:
Phone:
FAX:
Hokanson, Inc., D.E.
12840 NE 21st PI.
Bellevue, WA 98005
Duplex scanners
18
$1.3 M
Gene Hokanson, Pres.
800-999-8251 206-882-1689
206-881-1636
Company Name:
Address:
Contact Person:
Phone:
FAX:
Horizons Research Labs, Inc.
2155 North State Road 7
Margate, FL 33063
800-327-1074
305-974-2302
305-735-8500
Company Name:
Address:
Area(s) of expertise:
HunUeigh Technology
227 Route 33 East
Manalapan, NJ 07726
Hand-held "pocket" dopplers, Fetal ultrasound monitor
# employees:
# yrs in business:
$ annual sales:
Contact Person:
Phone:
FAX:
Notes:
400 (worldwide)
12 in ultrasonic, 23 in medical electronics
Andy Wood - Ultrasound Product Mgr.
800-223-1218 908-446-2500
908-446-1938
U.S. Subsidiary of Huntleigh Technology, UK., All R&D/Manuf. in UK.
Company Name:
Address:
# employees:
# yrs in business:
$ annual sales:
Contact Person:
Phone:
FAX:
Imex Medical Systems, Inc.
6355 Joyce Dr.
Golden, CO 80403
75
$6M
Tom Doggett
800-525-2519 303-431-9400
303-431-0429
Company Name:
Address:
Area(s) of expertise:
# employees:
# yrs in business:
$ annual sales:
Contact Person:
Phone:
FAX:
Institute of Applied Physiology and Medicine
701 16th Avenue
Seattle, WA 98122
Air-embolism detector
4
2O
$1 M
John Klepper, PhD
206-553-7330
206-553-1717
Company Name:
Address:
Contact Person:
Phone:
FAX:
InternaUonal Ultrasound Systems
12 Overlook Park
Rochelle Park, NJ
Raul Gutierrez, V.P.
800-736-1826 201-843-1807
201-843-2035
Company Name: Interspec
Address:
Area(s) of expertise:
# employees:
# yrs in business:
$ annual sales:
Contact Person:
Phone:
FAX:
110 W. Butler Ave.
Ambler, PA 19002
Duplex scanners
2O5
10
$57 M
Art Schenck, V.P.
8(X)-332-3246
215-540-9711
215-540-9190
Company Name:
Address:
Area(s) of expertise:
# employees:
# yrs in business:
$ annual sales:
Contact Person:
Phone:
FAX:
IntervenUonal Technologies, Inc.
3574 Ruffin Rd.
San Diego, CA 92132
Contract R&D
10
Herb Radish
619-541-2840
619-292-8381
Company Name:
Address:
Area(s) of expertise:
# employees:
# yrs in business:
$ annual sales:
Contact Person:
Phone:
FAX:
Kesa Corp.
4701 Patrick Henry Dr., Suite 1801
Santa Clam, CA 95054
Development company/contract research
9
10
Steve Ghlback, PhD, Pres.
408-748-1814
408-748-0664
Company Name:
Address:
KB-Aerotech
Box 350
Lewistown, PA 17O44
Area(s) of expertise: Ultrasound Transducers
# employees:
# yrs in business:
$ annual sales:
Contact Person:
Phone:
FAX:
Notes:
250
$18 M
800-233-7183
717-242-2606
717-242-0327
Owned by Emerson Electric Co.
Company Name:
Address:
# employees:
# yrs in business:
$ annual sales:
Contact Person:
Phone:
FAX:
Notes:
Kontron Instruments, Inc.
9 Plymouth St.
Everett, MA 02149
28O
$2 M
800-343-3297
617-387-2157
617-389-6400
Owned by Kontron Holding NV
Company Name:
Address:
Area(s) of expertise:
# employees:
# yrs in business:
$ annual sales:
Contact Person:
Phone:
FAX:
Konigsberg Instruments, Inc.
2000 Foothill Blvd.
Pasadena, CA 91107
Hybrid microcircuits, pressure transducers, custom subassy's
3O
$1.3 M
Bill Mills, Chief Engineer
818-449-0016
818-449-1086
Company Name:
Address:
Area(s) of expertise:
# employees:
# yrs in business:
$ annual sales:
Koven and Associates
13044 Ferncrest Ct.
St. Louis, MO 63141
Doppler vascular fiowmeters
Contact Person:
Phone:
FAX:
Notes:
Paul Koven
314-731-0008
314-731-2946
U.S. representatives for Hayashi Denki Co. (HADECO - Japan)
Company Name:
Address:
# employees:
# yrs in business:
$ annual sales:
Contact Person:
Phone:
FAX:
Ufe-Tech, Inc.
P.O. Box 36221
Houston, "IX 77236
86
$7 M
800-231-9841
713-495-7960
713-495-9411
Company Name:
Address:
Contact Person:
Phone:
FAX:
life Sciences, Inc.
West Lebanan, NH
Allan Heath
1-800-343-0693
603-298-5942
Company Name:
Address:
Area(s) of expertise:
# employees:
# yrs in business:
$ annual sales:
Contact Person:
Phone:
FAX:
Notes:
Medasonics, Inc.
47233 Fremont Blvd.
Fremont, CA 94539
Pulsed and CW Duplex scanners
100
21
Jerry Smith
800-227-8076
415-623 -0708
415-623-0626
Owned by Settsu P.B. Manufacturing (Japan).
Company Name:
Address:
Area(s) of expertise:
Medical Accessories, Inc.
92 Youngs Road
Trenton, NJ 08619
Transducers, EKG electrodes, Fetal monitors
# employees:
# yrs in business:
$ annual sales:
Contact Person:
Phone:
FAX:
Notes:
15
24
Janis Ziedonis
609-890-8304
609-890 -0638
Previous NASA collaborations. Competed w/Techno-Scientific for
design of previous ultrasound air-embolism detector for NASA.
Company Name:
Address:
Area(s) of expertise:
# employees:
# yrs in business:
$ annual sales:
Contact Person:
Phone:
FAX:
Millar Instruments, Inc.
P.O. Box 230227
Houston, TX 77223
Miniature pressure xdcrs, catheter ultrasound probes
48
15
$4M
Huntley Millar, Pres.
800-669-2343 713-923-9171
713-923-7757
Company Name:
Address:
# employees:
# yrs in business:
$ annual sales:
Contact Person:
Phone:
FAX:
Minntech Corp.
14905 28th Ave. North
Minneapolis, MN
2OO
$32 M
Dan Schyma
800-328-3340
612-553-3387
55441
612-553-3300
Company Name:
Address:
Area(s) of expertise:
# employees:
# yrs in business:
$ annual sales:
Contact Person:
Multigon Industries
559 Gramatan Avenue
Mt. Vernon, NY 10552
Transcranial doppler
10
Bill Stem
Phone:
FAX:
Notes:
800-289-6858
914-664-9502
914-472-1697
Formerly Unigon Industries
Company Name:
Address:
# employees:
# yrs in business:
$ annual sales:
Contact Person:
Phone:
FAX:
Notes:
Nuclear Associates
100 Voice Road
Carle Place, NY 11514
34
Martin Ratner, Dir. Mktg.
516-741-6360
516-741-5414
Owned by Victoreen, Inc.
Company Name:
Address:
Area(s) of expertise:
# employees:
# yrs in business:
$ annual sales:
Contact Person:
Phone (US):
FAX (US):
Notes:
Oxford Medical, Inc.
11526 53rd Street N.
Clearwater, FL 34620
Air-embolism detector, Ambulatory EEG, Holter, BP
35
25
$10 M
Jean Rizzo_e
800-237-8923
813-572-6836
813-573-4500
Owned by Oxford Medical, Ltd, (UK). All R&D done in UK. Oxford-"
acquired Sonicaid in 1987. UK R&D Mgr: John Francis (011-0235-
533433)
Company Name:
Address:
Area(s] of expertise:
# employees:
# yrs in business:
$ annual sales:
Contact Person:
Parks Medical Electronics, Inc.
P.O. Box 5669
Aloha, OR 97006
Air embolism detector (Model 915-AL)
6O
25+
$5 M
Larry Smurthwaite
Phone:
FAX:
800-547-6427
503-591-9753
503-649-7007
Company Name:
Address:
Area(s) of expertise:
# employees:
# yrs in business:
$ annual sales:
Contact Person:
Phone:
FAX:
Notes:
Philips Ultrasound International NA)
2722 South Fairview St.
Santa Ana, CA 92704
Duplex scanners
30 (in ultrasound)
Allan Schultz, Mgr/Marketing
714-241-5259
714-241-5420
Owned by Philips Medical Systems, NA
Company Name:
Address:
Area(s) of expertise:
# employees:
# yrs in business:
$ annual sales:
Contact Person:
Phone:
FAX:
Notes:
PIE Medical
3535 Route 66
Neptune, NJ 07753
Portable dopplers
18
15
$2.6 M
Mike Tunnicliffe
800-722-6400
908-922-3561
908-922-4888
Owned by PIE Medical (Holland). All R&D done in Holland.
Company Name:
Address:
# employees:
# yrs in business:
$ annual sales:
Contact Person:
Phone:
FAX:
The Probe Corp.
11662 Lake Shore Place
North Palm Beach, FL 33408
6
2
$1.5 M
407-626-4405
Company Name:
Address:
Area(s) of expertise:
# employees:
# yrs in business:
$ annual sales:
Contact Person:
Phone:
FAX:
Notes:
Quantum Medical Systems
1040 12th Ave. NW
Issaquah, WA 98027
Duplex scanners, vascular imaging
160
Ray Powis
800-367-3569
206-391-9161
206-392-9180
Recently acquired by Siemens Ultrasound.
Company Name:
Address:
Area(s) of expertise:
# employees:
# yrs in business:
$ annual sales:
Contact Person:
Phone:
FAX:
Notes:
Sarns, Inc.
6200 Jackson Rd.
Ann Arbor, MI 48106
Air detector for heart/lung bypass machine
240
20,000,000
Fred Gruhl, Dir. R&D
800-262-3304 313-663-4145
313-663-5062
Owned by 3M/Medical-Surgical Division
Company Name:
Address:
Contact Person:
Phone:
FAX:
Sclentronics Manufacturing
Flowerfield Bldg. 1
St. James, NY 11780
Kerrence Gaffington
516-584-6640
516-584-6806
Company Name:
Address:
Area(s) of expertise:
# employees:
# yrs in business:
Shimadzu Medical Systems
101 W. Walnut
Gardena, CA 90248
Duplex scanners, OB/GYN
32
$ annual sales:
Contact Person:
Phone:
FAX:
$5 M
Debbi Zane, Dir. R&D
800-228-1429 213-217-8855
213-217-0661
Company Name:
Address:
Area(s) of expertise:
# employees:
# yrs in business:
$ annual sales:
Contact Person:
Phone:
FAX:
Noms:
Techno Scientific, Inc,
60 Caster Ave.
Woodbridge, Ontario L4L 5Y9
Air embolism detector
5
6
<$1M
Victoria McDonald
416-851-9958
416-851-6314
Developed previous NASA doppler air embolism detector.
ing/Canadian Navy experience.
Div-
Company Name:
Address:
Area(s) of expertise:
# employees:
# yrs in business:
$ annual sales:
Contact Person:
Phone:
FAX:
Tetrad Corp.
12741 East Caley Ave., Unit 126
Englewood, CO 80111
Doppler module/designs for large ultrasound OEM's.
9
6
Said Azim, PhD
303-790-7239
303-790-2726
Company Name:
Address:
Area(s) of expertise:
# employees:
# yrs in business:
$ annual sales:
Contact Person:
Toshiba America Medical Systems
2441 Michelle Dr.
Tustin, CA 92681
Ultrasound scanners
1,300
$300M
Tom Jedrzejewiez, Mktg.
Phone:
FAX:
Notes:
800-421 -1968
714-832-3990
714-730-5000
Owned by Toshiba Corp. All R&D/manufacturing done in Japan.
Company Name:
Address:
Area(s) of expertise:
Contact Person:
Phone:
FAX:
Triton Technology, Inc.
P.O. Box 99179
San Diego, CA 92169
Doppler blooclflow meter
Scott Kemper, Pres.
800-872-1251 619-272-1251
619-272-1451
Company Name:
Address:
Area(s) of expertise:
# employees:
# yrs in business:
$ annual sales:
Contact Person:
Phone:
FAX:
Notes:
Universal Sonics Corp.
31 Industrial Ave.
Mahwah, NJ 07430
Contract/custom engineering for major ultrasound OEM's.
15
6
$1 M
Ron Hadani
201-825-8414
201-825-8516
Most Universal engineers were employed by J&J Ultrasound/'rechni- -
care before it was closed in 1986.
Company Name:
Address:
# employees:
# yrs in business:
$ annual sales:
Contact Person:
Phone:
FAX:
Vascular Technology, Inc.
25 Industrial Ave.
Chelmsford, MA 01824
12
$1 M
Dave Reagan, sales and marketing
5O8-250-O856
508-256-1325
Company Name:
Address:
Vistec, Inc.
17422 Sugar Pine Dr.
- Houston, TX 77090
# employees:
# yrs in business:
$ annual sales:
Contact Person:
Phone:
FAX:
32
23
$2 M
Ed Thibaudeau
713-444-6128
713-444-9474
Company Name:
Address:
Area(s) of expertise:
# employees:
# yrs in business:
$ annual sales:
Contact Person:
Phone:
FAX:
Waters Medical Systems, Inc.
2411 7th Street NW
Rochester, MN 55901
Doppler cardiac output monitor
215
$3M
Lou Harrold, Dir. Engr.
800-426-9877 507-288-7777
507-252-3700
Company Name:
Address:
Area(s) of expertise:
# employees:
# yrs in business:
$ annual sales:
Contact Person:
Phone:
FAX:
Zevex Inc.
5175 Greenpine Dr.
Salt Lake City, UT 84123
Air detector - heart/lung bypass machines
45
5
$2.5 M
David J. McNally, VP & Dir. Mktg.
801-264-1001
801-264-1051
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APPENDIX F
Responses to Request to Industry.

HOFFREL INSTRUMENTS, INC.

Your na_c:
Your organization:
OUESTIONNAIRE
RUSSEL L. UPHOFF Telephone #. (203)
HOFFREL INSTRUM_., INC.
866-9205
I0
2.
How many years has your organization been in the ultrasound marketplace.'? 2 8
How many cumulative engineering person-years of experience does your current staff have
in design of medical ultrasound equipment? 46
,
o
Does your organization have experience in design of battery-operated, medical, ultrasound
equipment (Y/N)? N....__O If yes, approximately how many cumulative engineering person-
ycars7 .--___ However we are presently working on a project of designing and
building a battery operated interface unit for operating transducers with the
Circadian Scanmate, a battery operated ultrasound unit.
Does your organization have experience in design of flight equipment (Y/N)?
Ifyes, please explain: However our Chief Engineer, Jack Schwarzschild, had such
experience with Norden Div. of United Aircraft and Corporate Systems Center of
United Aircraft.
m Does your organization have experience in design of ultrasound equipment spedfieally for
eirculati_ micr0bubble dete0ion (Y/N)? Yes .If yes, please exvlain:__ . __
Please rexer Do t/3e attacnea aaverr_a.se_aent: xor our'transesopnagea.J.r.ransctucer.
One of the major applications of this device is the detection of air emboli.
6. What are _ organization's uai_ue suengths in3he design of
Hoffrel's pabticu/_r expertise i_the des_gno_ ultraSOun=
1
_tr_ans_deres ._ e_?ve over
eighty different models, all designed for medical applications. For years we were the
exclusive supplier of such devices for both Philips and Johnson $ Johnson. Lately
our efforts have been directed _ the design of very small transducers, small
enough to fit between the surgeons fingers during various operative procedures. We
also design the scanming systems to support these transducer devices.
What patents or inteLlectual property does your organization hold which could be relevant
to this project?
U.S. Patents 4,834,102
4,977,898
St Will your organization be submitting a "Description of Technical Approach" by Friday,
November 1, 1991 (Y/N)?
My organization chooses not to submit a response to this request.
4
Page I
INTRODUCTION
The use of ultrasound to direct gab bubbles in the vascular
system is old technology. Thls can be Ieen from the attached
bibliography with numerous references dating back to 1968, 19a9
and the early 1970'I. Noteworthy are Maroon's work in
neurosurgery, 8illis and Spencer's use for decompression
sickness, and Spencer and Simmons' application to cmrdlac
surgery. Before an extensive development program is initiated,
it would be well to assembly these papers and use them as a guide
in setting up the actual experimental protocol.
Two quite different types of technology have been used for air
emboIism detection - doppler detectors and imaging systems.
Almost surely the final system will be a doppler type because of
the ease of miniaturizing this technology. However during the
development phase, an imaging system provides unequivocal
confirmation of the presence of bubbles. This is important since
the ultimate system is going to have to provide some automatic
means of recognizing the doppler spectrum produced by bubbles.
For this reason the recommended equipment is the Hoffrel Model
518SD which Is a duplex system providing both capabilities.
Since it displays the doppler spectrum, the development of that
essential automatic detector will be facilitated. Fortunately
Hoffrel also manufactures m transesophmgeal transducer which
provides views of e>:quislte clarity of the heart. This has
proven to be a useful tool for the anesthesiogist. One of its
most important uses Is to provide an immediate indication when an
operative procedure is introducing air into the vascular system.
As such it will provide an invaluable tool in deciding which
chamber provides the best indicator of decompression bubble
formation. A copy of Hoffrel'e advertisement in Anesthesiology
magazine is attached. Note the emphasis we place on detection of
air emboli.
BIBLIOGRAPHY Page
svr.to_,rgl('.l Appti¢'clllon_
Orossman BS, Wood Ell: Evaludllo. of cetebtovasctilnrdisease ullllzlnga Itans-
culaneo.S Doppler lechnic. Radiology 90:]B6=_87, 1968
_Aaroo. JC, Edmonds --t;enlJ, C.mpbell RL: Aft ullt,,so.lcmelhod for delecllon air
embolism. J Neotosllrl 31:196-201, 1969
Maroon JC. Pleron| DW, Campbell RL: Ophlhalmosonomelry: A. ultrasonicmelhod
for assessl.B ct_tolldblood flow.J Neurosurll :J0::_:JS--246,1969
Michenfelder J D, Millet R II, Clto.erl OA' EVllluallOIi of all ullraso.ic deHce (Doppler)
for Ihe dlng,osls of venous air embolism. Altesthesloloiy 36:164-167, 1972
Muller IIR: Direclioltal Doppler sotloireplly. A Itew technique Io demonstrate flow
reversal in the ophlhalmic arlery. Neurorndl0loiy _:91-94, 19?J
Spencer M P, Clarke H F: Precordinl mo.llorlnll o1"pulmonary. Bali embolism and decom-
pression bubbles. Aerospace Med 4_:162-161, IP?2
Spencer M P, t.swreltce O I1_ Thohtas (]l, el hi: The use ofullrasonlcs In Iha delerminn-
lion of arlerlnl aeroembolism diJrlnt opett-heutl surgery. Ann Thorac Surl 8:
489-497, 1969
Re('enl I)e,t,elcJpnleell._
Baker DW: l_llsed ullraso.lc Doppler blood-flow settsing. IEEE Ttans Sonics UI-
Venoue Air J_mbollom
I),'leollnn or minute yen..o nit- emboll with ulLrnnouhd. J.U. Mnroon_ M.O. Dept. ,! 8urKery. Die. of He,.roloil(--l _.".-. _'.
Indlnnl U. Med Ch'., IndlnnapoUl, Ind. 8urKery, oyneoololTT & SOarers'los. pp. IS36-1838. December. 10nO.
Air emlmllem dhllnoee4 with uitrtl;oUtid. J, E:dmondd-P_ni. kit), Hu||leld I)ep|. or Anaeethotlee. Ilnlted OR|sol IInR1,11nl".
F:.nKIm_! amdJ. C. Muroon, M.D. Imritlnh Journal ofAnneelheell. Yol. t]. No. S. pp. 438-440. July, IHI.
F.vnlunilo. ol nit ultrnionio devise (Doppler-) for tim dleBltoelo o! smnoUll 411" embolism, Jolm 13. Michen(elder, MS) et hi..
Anelllheliololy, Yol. ell, No. 21 PIP, 18d-18?, Pebrulr)', 107:1.
Cnrdlovneeulmr efreoea of _,enotto sir emboliem _l'lrq_ sir nt,d oxyi_, b_aUdnS. _effoyj Onulrer. amci I_l_r.
Aneitl._ala Jmd A.nJlreoin--Curz_ut Heeoltohel_ Yo|. 611, No, 4; J-iy-AulrMt, IOTe.
/_III_i l,uhhll_t)c.lecih,ll
I- _is'. drlrcil.n o| l:ll'eul¢lll.ll llnll emlmll n.xlx:l,lt, d _tllh ll{.cd|hltreilil., sll_k.ell. U.lliK lhc d,,pl,h_r lh.vmrl¢.l'. ,:IIII... , I ,I.
N.l.r,. Illrlll.l,). Vul. 21;o N,I. _iI:12, I'1'. i)r_-,07. Ahtl'eh 9. il)dS.
i*,.h-,.ll*,. ,,f K"# (.mS.,It nmln(:lnled t_lib d(,enllqd'O_l.!olt UIIIIIK Ihte d,@ldOl" II.. m_,l(,r. (.lillhl t.i al..I,,ur.id ul" (k-,..i,:.l*,,, ,1
S.h.,Ih.i.v. V,,I. It. 14u..rl. I_|.l.. I90d. "" '
II.'l, rlnl. o. Ihe nlmve h_'o h'om t+1, F. ulnii. D.v. ks. I)nllt.lll- H.l'lh(_'t0nt. Ilnllelh. Mew..I.I haiti.h,. PU II..s ,.-
II h-hinml. %1,'a_hlnK|Ull.
1 h- .._e .f ullrnnunieo I. Iht. dulorml.ntl.n ol ,|.lertnl nal_mmholl_nt dttrl,tg ope.-hudrl eurller_'. .'k,e.cer. el hi. "1h,., :,,-,,
+_,rRt',T. Vol. II. Nu. 0. I)P- 1_19-407. t)ecemhur. 1909.
Ile_.ol.l, me.I .( I.Jld,le0 I. vrn.un O|d lrlel'lnl hlaod durl.R hHt_14mrld tl_o,tnpt'eenlon. M. I'. Slw.cer. M.O. Ilt, li,.ll. ,,I
the Mn.n,l UII.Io. Vol. 2:1. Ho. I. M0rah. 19118.
I_._l,,,rlmrnle od de_ompl-ennlo_i I,uldd,I In the c/l_uld/lod Ull,t ,lll'dnoltlo at,J elr_:h-umnl_netlo ll.w,nelern. 91,era.,','. ,._ .,i.
Vitl[inl._ Mason neoedreh Ctt.. |000 Beile_ll Btrt.ol. Benille, walshlnldolt I)11101. Jo, r. Uccupnllunnl t.led. Vol. I!. I'p- _-:l_-
| ! I May. 1909.
A ,Inl,l,Irr Ilowmrlek for detoetl.I lilt _l,d other e,,lmll. Ilieu_ntith_R, ell.pie l,_elhM o! nereenlnR nKalnet Inlrrh._ ,'n,.,'.
t"llrden. P-. el II. Jt.lleelhenlolol_0 Vol. ,'1.1. pp. 8rtl-lll)|. Hovemliek+Ill10.
Ml..r,l, nrllclr dulecllod durlnl_ clrdl01mh_,lla_y hjlllillll. Blmmohll, Llehll. Klkndl. Bauer end Almond. Clrculnll,,. '_ I li _il.
t_,q,plenmnt Ill. O_ioher. 1070.
-,.h.r.nn ,,I' mlarnl,mrlleh,s ,lurlnK enrdlol_lllnomi _. IWlmAe I,_. Ullu nl ehs:lr,mle clt._'ire_.
Iq., , I.., ."'""',.ulm.nnr._, Anntelnm:,,. Adv.._.e_ in tnlxliul.l_l.. 9.1. s. April. loll.
,_llnl:l,,.s _'.. "I Ill. ilil.ril.'I.l,.',l
OR_G_NqL _:_ Ig
OF POOR q'U,_:tLI "i¥"
Page 3
PHABE
The obJectivi of the initial phase is to determine which vessel
or cardiac chamber should be monitored for the formation of
decompreislon bubbleI. It iI proposed that these experiments be
conducted on astronauts in a low pressure chamber at a NASA
provided siti. In ordir to complete the phase, NASA personnel
will have to bI trainId to operate thI Model 518 including the
tranmemophagIal transducer. Charles Tegler, M.D. - Assistant
Professor of Neurology at the Bowman 8ray School of Medicine -
has agreed to act as a consultant in order to provide this
function. Dr. Tegler has substantial experience in the use of
the Hoffrel 518, in the detection of air emboli and in the use of
the Hoffrel tranmesophageal transducer on awake patlenti. In
this respect ii should be noted that in 8ermany and in some
locations in the U.S. transesophageal techniques are uied to
monitor the heart during exercise tests.
Since Phase IiI the only part of the project that needs to be
done at low premiurIs, the doppler spectrum should be monitored
during thiI phaIe in order to provide information for the
automatic detector which must be designed during Phase III.
PHABE II
Once the decision is made ms to which chamber or vessel is to be
monitored, the project should move into phase II which is the
Ielection or design of a special transducer which can monitor
that chamber from a precordlal (external) location. Our present
thinking is that this would be done by modifying a Hoffrel Model
485(L) transducer. The Model 485 Is a scanning tranIducer
designed for Intraoperatlve use which im small enough to fit
between the surgeon°i fingers. Nith the Model 518 it can be used
for either imaging or doppler. The advantage of this duality is
that the image can be used to ensure that the transducer is
positioned so that the proper chamber Ii being viewed. Then a
servo system controlled by a cursor is adjusted to bisect the
chamber. The Model 518 can then be iwitched to the doppler mode
with full assurance that the proper chamber is being
interrogating. It iI expected that two modifications of the
Model 485 will be required. First, because it will be used
externally, the frequency should be lower than the 5.0MH=
normally used in the Model 485. This produces the dual advantage
of better penetration and a somewhat divergent beam so that the
positioning of the transducer becomes less crltical. The second
modification of the Model 485 would be the provision of a
mechanical lock io that the transducer is permanently fixed in
its optimal position. In this manner a special transducer is
produced for each astronaut in which the doppler beam is ideally
positioned for his anatomy.
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PHASE ZZ!
The objective of phase III is the design o4 a suitably sized
battery operated doppler device suitable for monitoring within
the EVA suit. No particular dl fflculty in this phase is
anticipated. The design o4 the automatic detector referred to
previously is obviously an important requirement of this part of
the project. Since previous users of air emboli detectors have
relied upon auditory recognition o4 the static, like noise
produced by the air emboli, it is anticipated that this
recognition process will be suitable for pattern recognition
using a microprocessor based system. Our initial plan is to
min_mlze the weight and power consumption by using an ASIC for
analog signal processing and m CMOS microprocessor for all
control and data handling functions.
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PRO3ECT COST ESTIHATE
Z. Phase 1.
A. Duratlon:
B. Cost
I. Labor:
2. Material :
3. Total :
8 months
$59,000
55,000
$114,000
II. Phase 2.
A. Duration:
B. Cost:
1. Labor:
2. Material:
3. Total:
4 months
$32,000
15,000
$47,000
III. Phase 3.
A. Duration: 6 months
B. Cost
1. Labor: $124,000
2. Material: 21,000
3. Total: $145,000
IV. Summary of total program.
A. Durmtlon:
B. Cost
18 months
$306,000
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Your organiza_on:
John R. Klepper I Ph.D. T_tepbone #: 206/553-7330
Fax 206/553-1717
Institute of Applied Physiology
and Medicine
5
1
1
How many yc_ hasyouror_don been hl_e u_=a_oundmarketplace? 2.____0
How many c_muiadve engineering person-years of_e_c= does your cu_e_ s_ _ve
de_gR of me_ _m_ound eq_pm=_? .._. years in full-time engineering
personnel + 1 part-time engineer with 10 years of experience and one
physician _r£th 25 years of experience.
Does yourorgm_L_adonhave='per_c= m d_gn ofba=_ry-opemtc_ med_ ul_ound
=qu/pme=_ CY_N)? _ _ye_ appra_=na_y how many cun_a=ve eo,_.,u,.-.:ringpermn-
yea2S? 37
u
Does your orgamza_on have _pe_en= m d_signof_gb: cqu/_r CY/N)? _z__
Ify_.%ple_se_la£_ Performed a phase I feasibility study for theUSAF
School of Aerospace Medicine on an in-suit Doppler decompression sickness
monitor, contract #F33615-C-83-0618 from August 1, 1983 through July 31,
1984. We have also built and installed transcranial Doppler and associated
spectrum analysis equipment for the human centrifuge at USAF SAM.
1
Does your org_n_don have experiencem d:sgn o_u_-_ound equ/pmem s_ca_y for
drctt[a_g mi=obubble de_ccdonCY/N_? _L__ Ify_ pleaseexptaim The Institute
has marketed Doppler bubble detectors to other research labs since 1971. The
Hadel_1032L_dSl_ala£mple_o_UralLC_. Dop_lert_bubble detector Ls_l_Lunde 'r_-he
S0u_n_Prpducrs_ Di_islonf.labe I= _In ee_q_'7q. Thei_Mod el- 1058-:_j_ _stere=_C_
Dop_er_hubhI_:_detec_or__La_canced_des_lsold_slnce-1982. We have also
developed a cerebral emboli monitor which detects both bubbles in the
cerebral circulation during surgery and formed element emboll passing through the
V_r_ Er_ youl or_I_za_oIl_$ _3/_le __ _ _ d_l of LLI_asOU,_ eq_t? cerebral
The Bioengineering Department of the Institute specializes in ultrasound circulatic
Doppler instrumentation and signal processing. In addition to CW and
pulse Doppler electronics and standard spectrum analysis, the Institute has
developed real-tlme pattern recognition systems for specific vessel identi-
fication and emboli detection and quantitation. We have an active hyperbaric
medicine program that has done Doppler bubble studies of decompression
_sickness since,19?/.
W3a_ palcn_sorm_t/[e_n_lpropertydoesyourorgamzadon holdwhich couldbe r=l=wm
_t_sprojec_7 I) Proprietary designs for both CNand pulse Doppler electronics.
2) DSP designs for data acquisition, spectrum analysis, and pattern recognition.
3) US Patent #5,052,395 contains pattern recognition techniques possibly of use.
4) A patent application is in process on the cerebral emboli monitor.
8_ W_ your organL_fion be submi_/nga "DescriptionofTedm/_ A_proach"by Plid_y,
Nov_nber I,1991_Y/N)? _Z___
My organiz_uonchooses=o_ _osub_ a :_spomc :o_ requesu
DESCRIPTION OF TECHNICAL APPROACH FOR AN IN-SUIT ULTRASONIC
BUBBLE DETECTOR FOR EVA
The presence of nitrogen gas bubbles in the pulmonary artery
has long been recognized as a possible precursor to the
occurrence of bends. Ultrasonic detection of these bubbles using
CW Doppler instrumentation has been in practice for some time.
However, the results of these exams were generally evaluated
subjectively by a trained and experienced observer. Recent
technological advances and clinical research in this field
indicate that quantitation of the number of bubbles passing
through the pulmonary artery is now technologically feasible.
We propose a plan to provide an automated real-time
identification/quantification system to determine bubble grade in
the pulmonary artery.
Key elements in an in-suit bubble detector design are the
following:
1) Doppler electronics,
3) pattern recognition algorithms for identification of
pulmonary artery signal,
4) pattern recognition algorithms for detection and
quantification of numbers of bubbles passing through the
pulmonary artery,
5) recording and telemetry instrumentation.
Each of these major components will be described below.
This--_ystem_s_e_:_ed_to_operate_ini_OO_percent-oxy-gen
_mosphere_at_an_amhi_eri__pressuredof_:4_2S_. Several constraints
result from this requirement. Since fire hazard is the most
obvious danger, materials used must not have any volatile or
easily flammable components. Electronics must be designedLt_
operate-on-low-voltage, low power, battery operation. Potting of
the electronics must be considered to prevent the possibility of
arcing or spark due to static electrical discharge.
i. Doppler Electronics
_=__2_5_a_LiS__Op__p_r0Pose_ Much of the
published literature on Doppler bubble detection incorporates the
use of 5 MHz CW Doppler. From general scattering theory, it
appears that such bubbles should be just as easily detectable at
2 to 2.5 MHz. _se_of_long_range_-gate_pu_se_Doppler
Sho_l__functfO--n__as_we_l_-as--a_rueuCW:Dopp!_r. These
hypothesis have been essentially confirmed by the recent reports
of detection of both bubbles and formed element emboli in the
cerebral circulation using 2 MHz transcranial pulse Doppler. We
anticipate the use of pulse Doppler to be better than CW for this
application since the use of range-gating should significantly
reduce the amount of clutter from stationary and slowly moving
targets such as heart and vessel walls. A pulse Doppler sample
volume will also provide greater bubble-to-blood signal contrast
than CW, thereby increasing the detectability of microbubbles.
2. Transducer Array and Controls
A 2-dimensional array of transducers operating in the
frequency range of 2 to 2.5 MHz is proposed. The number of
transducer elements would need to be determined by computer
simulation of beam patterns. T_amsducer_elements_wouldd_obab_
number_betwe en_9_mnd_. _ _ hexaqonal_cl o se_ pack_- geomet ry.
T ransduce rs_w6_d/-b_m6unted--in_a--conca'v_1 o--w_p_of i Ie: p_ a s_:f_
hqus'x_g/_an_otul_e_d_gned_to cover a broad_sample-volumed--of
depth--range--from_5_t__here--the-best-signal_from_the
pulmonary_artery_would_J_ikely_be_loca_ed. Double quarter wave
matching layers would be used with a goal of a round trip
insertion loss in the range of 6 to 8 dB. Some existing designs
of such transducers are air-backed with an inductive tuning
element. The low pressure, i00 percent oxygen environment
requirement might obviate the use of an air-back transducer and
require a rigid back instead. _t_s-anticipated-that-a--large
number-_if_/_o_-_of_the--aTl--e-lements-would_bedriven--i_parallel-r_t
a_ow_peak--transm±t-voltage_probably-on_the'_order-of_Sto_
_dI_t_-_eak-to-peak_ Switches would be available to select the
operation of each transducer for both transmit and receive. The
_zr_._at_the_pu zmonary_a r_ e ry _s i'gna l_can_be_obt_ fned_af_erT, th_
__ or scum f_th-_A_ u-ft-M as_ e'eh_pu--E_6n_. An appropriate
adhesive material needs to be specified to provide the ultrasonic
coupling from array into the body. A likely candidate is the
material used for ground return electrodes for electro-surgical
apparatus which adheres well to the skin but does not adhere to
hair, thereby obviating the need to remove any chest hair from
the astronaut.
3. Pattern Recognition for Identifying Pulmonary Artery Signal
The pulmonary artery Doppler waveform can be easily obtained
from the precordial position typically using either the second,
third, or fourth intercostal space in a short access view. Since
individuals undergoing EVA from the space shuttle are _i_y
;%_, it will be possible to positively identify this
signal in terms of its normal range-depth and location for each
subject as well as identify the characteristic waveform for that
subject; all of this being done in routine echocardiographic,
ground-based studies. This information can be used to provide an
example of the normal pulmonary artery waveform for that
particular subject. Barring pathology, this waveform should also
be relatively similar from subject to subject. A_atte_
re cog_-__h_b-_se_up on_-the =sub 3-e-6t"s_s o_n _i mona ry
art_j_%_aveT6_m_suTed--IT_ground=based_st_/d.ies_could_be_use_
Our approach to the pattern recognition would be to apply
Karhunen-Loeve, or principle component analysis to the pulmonary
artery velocity profiles obtained in ground-based studies.
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We have previously demonstrated this technique in real-time
pattern recognition of the aortic Doppler maximum frequency
waveform from the ascending aorta. It_maynbe-necesSary_to
p_c_ide_interactior_ from this _pattern_recognition-algorithm and
t_l_orithm c__l ing-the s e i e ct i o n _f_t_sq_e r" el em_-t_--so _
t__os s fbl e Cto_" 1 o-ck_o n'_the-pu Imonary_artery- s ignal-w* th
4. Pattern Recognition for Quantification of Bubbles
We propose to adapt our existing algorithm for
identification of embolic signals in the Doppler spectra from the
cerebral arterial circulation measured with transcranial Doppler.
This is a matched filter approach relying upon the knowledge of
the bandwidth and continuity of the Doppler signal from a bubble,
denoted by its increased amplitude over the normal background
Doppler blood flow signal.
5. Telemetry and Recording Electronics
Several known limitations on the design include the lack of
telemetry channels available on the EVA suit and requirement for
potential 6-hour duration of operation on a single battery pack.
These two constraints point to the likelihood that the eventual
package needs to be oper___a_termf-t_cen-t_-_6_. It is
desirable to put the minimum amount of electronics necessary
within the EVA suit itself. This would include the Doppler
electronics, transducer array, battery pack, and a means to
store, at least temporarily, a buffer of Doppler data which could
be passed to additional processing electronics. These?_additionel
electro_cs_wo_d-be-ho_ed'on_the_support_s_te-m_6nthe.bac2c_of
the_VbXs_Z%. The pattern recognition algorithms would operate
on digitally stored data in the support pack. Once the data is
processed, it could'be modulated over-the-low frequency_end of
the__voic_-radi_-channel-t_-the shuttle. The duty cycle of this
intermittent operation is undetermined at this point. Typically
;_;/ ::% _,_ L'JA TY
in ground base studies, subjects are monitored briefly for 30
seconds to a minute at 15-minute intervals. Such intermittent
monitoring during EVA is practical, resulting in 12 to 24 minutes
of full monitoring data in a six hour period.
BUDGET ESTIMATE
Three phases of development are needed:
i) A development system with no size constraints to
design and test the pattern recognition algorithms and
transducer array and controls,
2) Reduction of the development system to an
operational breadboard system meeting the size
requirements,
3) Construction of the flight model.
Phase 1 would be accomplished using existing IAPM designs for the
pulse Doppler electronics and Digital Signal Processor boards
necessary for the pattern recognition development.
Phase 1 is estimated at 8 engineer-months, 2 senior
scientist months, and 1 engineer technician month, plus $20,000
in materials to build 2 working arrays. Labor cost: $103,700;
Total Cost: $125,000.
Phase 2 is estimated at 24 engineer months, 4 senior
scientist-months, and 6 engineering technician months.
Total Cost: $320,000.
Total of Phase 1 and 2: $445,000.
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Your __a: MedaSonics, Inc.
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e How maW cun_dal:ivce._n"ing penon-years of _ does_ ¢m"rm_stiff have
in designof medical_t_ equipment? le....._._
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If_ p. __M4 _:l_]a/XU_ Medasonics has delivered _Tanmcranial
Doppler equipment to NASA for tests in zero-G airplane
flights. In addition, the engineering manager, Dr. G.
Smith, was employed by McDonnel Douglas Astronautics where
he worked with the electromagnetic compatibility group for
the Skylab Orbital Workshop in 1972.
seaasonzcs D-8 Veria_0ne -Do-_ler unlt, Wi_ "iTt& "
accompanying PSI probe is designed specifically for
precordial monitoring for air emboli in the right atrium of
the heart during neurosurgical procedures. In addition, a
new transcranial doppler system in development will include
air/particle embolic event deteotion as a stan_ar_ feature.
Wha_ _r_ your orsan/za_ion's unique strengths M The_ o__ _xmaff
Medasonlcs has been manufacturing battery powered ultrasound
equipment: for medical applications for 21 years.
pstesm or int#.llec_l property does your orlpm_=sdo_ hold Which mum be
to this _
Medasonics currently has a patent pend_g on a method of
detecting air/particle embolism which minimizes false alarms
due to probe motion artifacts.
&
My organ/zatton chooses not _o submit a respome to tiffs mqucE.
APPROACH FOR GAS MICROEMBOLUS MONITORING
I. INTRODUCTION
This document provides a brief outline of Medasonics' proposed
approach to the microembolus monitoring unit which NASA is
considering developing.
Based upon many years of experience with our customers"
successful use of the D-8 Versatone CW Doppler unit in the
operating room as a monitor for gas emboli in the right atrium
of the heart, Medasonics proposes that NASA's system be based
upon CW rather than pulsed operation, resulting in
significantly simpler electronics, lower power, and higher
reliability.
Medasonics submits for consideration several options to the
development, ranging from configuring a system from existing
components with a custom-designed controller, through
developing sensors which would be more resistant to artifact
and more easily applied.
IIo EXISTING TECHNOLOGY
Medasonics has already developed compact CW Doppler
electronics (designated Uniprobe) using thick film technology
on a ceramic substrate measuring about .75" x 4" x .5". In
addition, Medasonicscurrently manufactures the PSI probe for
detecting bubbles in the right atrium of the heart. This
probe, which measures about 1.3" in diameter and about .4" in
thickness, is attached using adhesive tape and operates at 2.4
MHz. It has a broad beam profile and is large enough to be
quite stable after application. By using this probe, a system
could be configured relatively quickly and some preliminary
measurements could be made midstream in the development
(perhaps on subjects wearing the suit in a vacuum chamber) as
a check that the general approach is viable and as a means of
limiting the risk of unforeseen problems.
Using the same electronics, Medasonics recommends configuring
a neck probe similar in construction to our P94A which
consists of a pair of piezoelectric transducers mounted at an
angle to the surface of the skin, permitting continuous
monitoring of the carotid artery. With this probe, the
presence of gas emboli to the brain could be checked, thereby
assessing the risk of serious neurological deficit due to
embolus formation. Because emboli in the path to the brain
could potentially present the greatest risks, Medasonics feels
that the small incremental costs in funding and installation
time would be a wise investment.
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Medasonics recommends applying self-adhesive sensors
consisting of Kynar (tm) piezofilm near to the ultrasound
transducers to detect motion artifacts. Medasonics has
constructed such sensors for detecting respiratory motion, and
the signals from these sensors could be processed to detect
periods of vigorous activity which would likely give rise to
probe motion artifacts from the ultrasound transducer. The
controller would monitor these sensors to squelch or otherwise
disqualify the detected ultrasound audio signal.
III. PROBE ARRAY DEVELOPMENT
Medasonics does not recommend developing an array of
transducers to automatically find or track the right atrium of
the heart or the pulmonary artery. We developed an automated
(motor-driven) mount for a pulsed transcranial Doppler unit
designed to position a probe to automatically locate, in two
axes of translation and two axes of rotation, the signal
returned from major arteries in the brain. We found that,
although the unit is often able to find its target eventually,
the search can be time consuming and was not always successful
unless aided by manual intervention. Since positioning the
precordial probe involves a two-dimensional search and is
relatively easily done by an individually with minimal
training, we feelthat funds invested for automatic searching
on this area would not be wisely spent. If necessary, the
proper probe location could be identified and marked on the
crew members before flight.
Since the neck probe for monitoring emboli in the carotid
artery must be more carefully positioned (due to the smaller
cross section of this artery), we propose that an inexpensive
linear transducer array be developed to simplify locating this
artery. This array would be designed to be self-adhesive
rather like a Band-Aid, and could include the Kynar material
for motion artifact detection. As mentioned above, the risk
of neurological deficit from gas emboli to the brain could
pose serious risk to both the crew members' safety and the
mission objectives, so providing an index of the level of gas
emboli in the carotid artery could be an important component
of the system. Furthermore, this is the area that Medasonics
feels would hold the highest promise for commercialization,
since we believe that monitoring for gas emboli to the brain
during cardiac procedures will eventually become a standard of
care.
IV. PROPOSED ELECTRONICS
The breadboard would employ Medasonics Uniprobe electronics
described above for the CW signal generation and quadrature
demodulation, along with switches to select between the
precordial probe and the neck probe (or neck probe array
elements). A microprocessor would control the RF switches and
automatic power down so that the system will be active for
mp. 3
only about 1 minute every ten minutes to conserve battery
power. The microprocessor also monitors the Kynar output
voltage to reduce artifact. Finally, the microprocessor would
digitize and FFT the sampled quadrature data, and use the
peaks in the spectrum to further qualify whether strong signal
returns are due to bubbles or to probe motion artifact,
employing an analysis technique developed at Medasonics. The
system output would include the demodulated ultrasound audio
signals along with a digital data stream indicating when a
bubble has been detected and the sensor which detected the
bubble.
V. PROGRAM PHASES AND APPROXIMATE COSTS
This section indicates the proposed phases of the program and
makes an initial rough estimate of the cost for the program.
These estimates are rough order of magnitude figures based
upon the limited information currently available, and are not
firm quotes.
Medasonics does not currently manufacture special, limited
production devices on a contract basis, and it is not our
intention to enter this business. Medasonics" interest in
this program is to develop products for which we would own the
manufacturing rights and which we could freely market.
Phase I - Concept Demonstration
Configure Medasonics' current P81 probe and a separate
P94A angled probe for the neck, each driven by separate
Uniprobe electronics, together with Medasonics
Cerebrovascular Diagnostic System (CDS) to monitor for
gas emboli in tests of the suit in a vacuum chamber.
This phase will verify the concept, and will allow
convenient test bed for developing any algorithms
required, optimizing bubble detection thresholds at
various sites, and providing a test fixture and reference
for performance comparison against the final delivered
breadboard system. Estimated costs are on the order of
$75,000.
Phase II - Neck Probe Array and Compact Electronics
Develop an array transducer for the neck, allowing the
transducer with the best carotid artery response to be
chosen automatically and incorporating a piezofilm for
motion artifact elimination. Concurrently develop
compact breadboard electronics that will operate in
conjunction with RF switches and existing Medasonics
Uniprobe electronics to allow the piezofilm and
ultrasound sensor information to be combined and used to
generate bubble detection signal output. Estimated costs
are on the order of $250,000.
MEDICAL ACCESSORIES, INC.
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Your name: Mr. Janis G. Ziedonis Telephone #: _1-609-890-8304
MEDICAL ACCESSORIES, INC.
Yo%IrOYg_tion: . 92 youngs Rd.
Trenton, N.J. 08619
I# How many years has your organization been in the ultrasound marketplace? 16.___years,
each key personnel and overall 24 years experience for each key empl.
How many cumulative eng/neering person-years of experience does your current staff have
/n design of med/cal ultrasound equ/pment? 8 4 ye a r s.
t
9
Does your organization have expeMence in de,sign of battery-operated, medical, ultrasound
equipment (Y/N)? Ye s _ yes, approximately how many =umuLati_. engineering person-
years? ,84 We'_-esigned battery operated equipment for Hof _m_nn
Ea Rocne'_r fetal heart detection and for blood pressure measuring
equipment and for Medical Accessories, Inc. (our own company) minia-
_pocket dpp_le_fetal heart detector.your orpnmmon nave experience in design of _ght eqmpmcnt (Y/N)? _ed
_p]_#_p_ Our company, Medical Accessories originally
worked and developed the equipment and transducers for NASA Space
Center to detect the bubbles in the blood stream. The evaluation
of the design was done in Houston Tx. Our prototype equipment was
never put in actual flight conditions, only in lab testing.
o
6_
Does your organ/zat/on have experience in design of ultrasound equ/pment specifically_ for
levelo
cit_ II_'O_;llb_le detection (Y/N)? Yes If ye,_ _]e_ explaJ_ We c pad
equipment for Air Emboli that operated at 2_ MHz,clinically used
in operating rooms for at least 15 years. Commercially the equipment
was known as Embosonde, Model 2000, sold by Roche Medical Electronics.
Even today there are some units used in Hospitals.
What arc your organiza_on's unique strengths in _e design of _trasound equi'p_ment?
The key personnel designed ultrasonic equipment for hospltals concen-
trating on equipment for ultrasonic blood pressure , air emboli,
fetal heart rate detection and designing laboratory equipment to
simulate the air bubbles, fetal heart motion and blood pressure.
s What patenm or intellectual property does your organ/zat/on hold wldeh cou/d be relevant
to th/sproject? A number of our key personnel have multiple number
of Patents in the design of ultrasonic transducers and electronic
circuits for medical applications. We have published well over
two dozen papers in ultrasonic use of equipment in medical field.
| Will your oration be subnlitting a "Des_ptton of Technical Approach" by Friday,
Now_ber I,1991 (Y/N)? Yes_
My organization chooses not to submit a response to this request.
1.0
• t
Introduction
This proposal outlines in general the technical approach
for the design and development of an ultrasonic sensor to
detect the presence of intravenous air emboli in the blood
stream as it returns to the heart from different body tissues.
The sensor will be designed and developed in a miniature
configuration, not to exceed your specified requirements.
Since our company originally worked on the concept with
NASA personnel in Houston, built preliminary equipment,
we still have the miniature multielement transducers and
by now have reduced the electronic circuits to hand held
probes. By changing the frequency of operation we have _!,_
the units used for other applications.
Analysls of the bubble wave form and frequency characteristics
when illuminated with ultrasound must still be performed.
This will simplify the circuit design so it responds mostly
to air bubbles and not artifacts or heart beats.
We al_o designed a special transducer support strap that holds
the transducer in place. Also a special vest will be designed
to support the electronic package.
After testing, evaluating and acceptance of one miniature proto
by NASA, one flight test unit could be fabricated according
to NASA requirements.
2.0 DESCRIPTION OF EFFORT DURING PROTOTYPE PHASE
Our existing miniature electronic circuit will be rede-
signed and miniaturized so it would meet your requirements
and fit easily under the space suit. It is battery operated
already. External battery recharging circuit could also be
added if necessary.
To obtaing optimum and correct information about the presence
air emboli condition in the blood stream, the type of signals
received when ultrasoun illuminates air bubbles must be
identified. Since we already have tape recordings of the air
emboli signals from our previous work with NASA on this pro-
ject, detailed identification and analysis of these signals
will be performed. Knowing the wave form and frequency of the
signals will permit to redesign the circuit that will respond
to these type of signals more effectively without using human
ear as a reference and record them when they occur. Once this --
has been accomplished an alarm system could be added, not
m_ 2 _m
2.1
2.2
2.3
3.0
4.0
5.0
part of this proposal, to alarm the individual of presence
of air emboli condition in the blood stream. .
MAI will rent a special high speed waveform analyzer equipment
that will capture and record the air emboli signal waveform and
frequency. Once the signals have been identified, miniature
circuit will be designed that responds primarily to the air
emboli.
Physically a miniature 5 MHz battery operated transmitter-re-
ceiver circuit will be built to operate the transducer, detect
the air emboli signals with the artifact rejection circuit.
MAI will perform in house testing for acceptability and perfor-
mance of the new circuit using our previously designed bubble
generating system and the tapes that we have from our previous
contract on this project. Then with MAI's personnel at NASA
we will help to operate and evaluate the system in simulated
conditions in altitude chamber. The prototype circuit will ."
be packaged close in design and size to the final unit to be
delivered to NASA.
Transducer and It's Support Design=
A new th_n 5 MHz ultrasonic transducer will be designed that
will snap on a U-shaped transducer support bracket. This bracket
will fit on individual's chest and hold the transducer at the
preselected area during the monitoring and exercize period. The
U-shaped bracket will provide the necessary continuous pressure
on the ultrasonic transducer so a technician does not have to
hold it in place during tests. This U-shaped bracket is separate
from the vest that would be used to hold the electronic circuit.
Since there are many different design techniques that could be
used for detecting the air emboli,one approach is shown in
Fig. 1. As additional detailed information is obtained this
design could be changed to achieve optimum information and
performance. A possible time table that could apply to this
project is shown in Fig. 2.
The approximate cost for developing the prototypesystem,including
special test equipment rental, redesigning the circuit,designing
artifact rejection circuit, transducer design, special transducer
support strap design,EMI proof housing design,lab testing and
evaluation of the equipment at NASA Space Center would be
approximately $ 130,000. range.
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Sonicaid Products
STAGE A
Objective
To produce an insmnnent that would enable the concept of an ambulatory microbubble
detector to be evaluated. The instrument would be suitable for ground based clinical trials
and for bench performance characterisation.
Requirements
I. Transducer to site interface.
We would supply an existing multi-crystal, wide angle, low profile ultrasound
u-az_tucer. This can be glued to the chest using adhesive ulwasound coupling
glue, however we would recommend attachment by means of a special purpose
buckle and belting which has been proven in both supine and ambulatory work.
2. ArffactRejecdon
The Stage A instruments would enable ambulatory artifact to be assessed.
Experience has shown that gas bubbles above a certain size give a characteristic
pattern to the frequency envelope of the reflected signaL Below this size, their
reflections may be indistinguishable from those of red blood ceils. Digital signal
processing techniques would enable the characteristic signal to be extracted fl'om
moderate levels of ambulatory noise. An additional source of artifact may arise
fi'om the cooling garment if the water used is not pure and degassed.
3. Dynamic Range
No additional work is envisaged here. We have specific expertise in maximising
dynamic range for all our ulwasound products including blood flow analysers and
fetal heart dem_o_.
4 Transducer size
See 1. above. The wide angle u-ansducer would enable fi_l trials to be conducted
and may be suitable for the final application.
Power
The existing instrument has a four hour battery capacity. This would be increased
to 6 hours with little difficulty for the Stage A units.
Sonicaid Products
.
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9.
Weight
The existing instrument would be repackaged to meet the weight limitation. This
would not involve technical risk.
Volume
Repackaging would achieve the required volume, again without technical risk.
Operating Temlm'atum.
The operating temperature range is exceeded by the existing insmmzent.
Operating atmosphere.
ALl our instruments arc designed to meet international medical safety smnda_rds
including UL544 and IEC601. Additional requirements for inn'insic safety would
need to be specified and taken into account in repackaging.
Tasks Required
The tasks required to achieve the above requirements arc not considered to involve
significant technical risk. The Stage A instruments would be based on existing
technology with some circuit changes and repackaging. We would estimate the design
changes to cost approximately $40,000 and the unit cost to be in the region of $5,000.
Thus fl_ce Stage A prototypes (the practical miniml]m) wouid involve a total cost of
about $55,000. Delivery would be within 20 weeks from placement of order.
Trials, Performance Characterisation and Further Development.
We would consider the above to be an essential precursor to the bench testing and trials
which would be necessary to test the concept and develop the final product.
Ethical and practical problems in running human trials involving gas microbubblcs call
for the use of bench modelling where possible. Air bubbles could be injected into
artificial blood circulating in a phantom. The size and quantity of bubbles could be
determined by optical or other means and correlated with the instrument output. A digital
signal processor would sample the output and the sensitivity of the algorithms would be
adjusted to detect the required level of bubble activity. Ambulatory human trials on
normal subjects, without gas bubbles, would enable the algorithms to be tested for false
positives and adjusted ff necessary.
Following this work the system would be ready for vacuum chamber trials which would
presumably be under NASA control. The resul_ of these would enable the final product,
Stage B, to bc designed.
Sonicaid Products
Summary
Stage A equipment could be provided with little technical risk. This would enable the
concept to be tested and the final product developed.
I hope this assessment meets your requi_ments, and I look forward to hearing fi'om you.
Yours sincerely,
John L. Francis
R & D Manager.
TECHNO SCIENTIFIC, INC.

OUESTIONNAIR_.
Your name: o,_. _e,:: _^cec,,_.
Your organizadon: rec_o _c,e_T_,¢.. INc..
Telepho_ #: _,<,)est-_
.
2.
e
How many years has your organtzadon been In the ultrasound marke_lace? t QO
How many cumulative engineering person-years of experience does your current staff have
in design of medics/ultrasound equipment? 20
Does your organization have exper/enee/n design of battery-operated, med/eal, ultrasound
equipment (Y/N)? _ If yes, approximately how many cumulative eng/neerJng person-
years?
4_
5,
e
e
Does your organ/zatlonhave experiencein designof flightequipment (Y/N)?
Ifyes,please explain:
Does your organization have experience in design of ultrasound equipment spedflcally for
circulating m/crobubbl¢ detection (Y/N)? _ If yes, please explain: wF.. _...,_-_F_
Wh_ are your organlzatlon's unique strengths/n the design of ultrasound equipment?
-_JPOa_._'. W_ ALSO AA_ _(-TtUF_ J_ UL_T£ASO_LC NO1- |NSTRO._-t_.._T-
What patents or intellectual property does your organ/zadon hold which could be relevant
to this project?
.
Will your organization be submittinga "Descriptionof Technical Approach" by Friday,
November 1, 1991 (Y/N)?
El My organ/zation chooses not to submit a response to this request.
TECHNICAL APPROACH TO AN
WIN-S_T ULTRASONIC DOPPLER BUBBLE DETECTOR"
_ntrodu_ion
Techno Scientific Inc. (TSI) was contacted by LSR Incorporated to
submit a "white paper" on our technical approach to the development
of an "In-Suit Ultrasonic Doppler Bubble Detector for EVA".
TSI responds with a brief description of the DBMg008, an ultrasonic
doppler bubble monitor designed and manufactured by TSI and the
DBMg008i, an in-suit version of the DBMg008 developed for both NASA
and DCIEM (Canadian Defence and Civil Institute of Environmental
Medicine). Also included is a section outlining the modifications
to our existing equipment that will be necessary to meet your
specified requirements.
Technical DescrImtlon of the DBMPg08 and DBMg008i
The operation of TSI's current Ultrasonic Doppler Bubble Monitor
is based on the Doppler effect on an ultrasonic wave transmitted
into and reflected from anything in motion below the skin surface.
Bubbles are detected by monitoring the ultrasonic signals reflected
from the blood stream and by listening to and classifying these
signals. This reflected signal contains information about the gas
bubble content as well as the blood flow rate. The blood flow and
heart beat are clearly audible.
Our existing DBMg008 utilizes a 2.5 MHz ultrasonic transducer in
CW mode to detect the presence of gas bubbles in the bloodstream.
TSI has received the best signal response from placement in the
precordial region. The optimal focal length for this region is
found to be 7cm. The existing electronics consist of a
transmitter, an analogue receiver/demodulator and various filters
to provide audible recognition of bubble flow.
The unit has an automatic gain monitoring circuit to prevent
distortion when the heartbeat occurs and provide enough gain to
detect _ size bubbles. It is powered by a 9V cell and lasts
approximately i0 hours. Control signals are available to record
the output of the unit and predefined intervals for a preset time.
To measure the blood bubble content, a transducer is placed against
one of three possible body sites (the precordium or one of the
subclavian veins) of the subject being tested. A harmless gel is
used as a coupling agent between the subject's skin and the probe
surface. A continuous wave ultrasonic signal is transmitted and
the reflected ultrasonic signal is received and processed by the
system's electronics.
JThe signal output can be listened to by an operator using
headphones or by recording it on a standard cassette unit for
playback at a later time. The existing concept requires training
to teach the user or operator to recognize the sound of the
bubbles.
The DBM9008i utilizes a smaller transducer, with approximate outer
dimension of 2cm X 3cm, a smaller enclosure for the elctronics and
a self-contained tape recorder. Except for the size restrictions,
this unit matches very closely the unit specified in the LSR
requirements.
Modification Requirements
The current transducer design will be modified to accommodate low
profile and interface specifications. TSI has already investigated
several methods to adhere the unit tot he chest and will experiment
with these to select the optimal method based on use in space,
range of movement and clothing restrictions. The possibility of
a self-coupled transducer head will be investigated.
We are not sure that the array approach outlined in the LSR block
diagram is necessary or that it indeed will be beneficial. We also
are convinced that CW mode as opposed to pulse operation mode is
superior as bubbles can be missed through continuous switching.
This is based on previous research.
Operating atmosphere
TSI will ensure that the unit(s) contain no exposed wiring that
will be affected by the oxygen atmosphere. Our previous experience
with NASA revealed that the recording medium presented a major
safety risk because of the oxygen environment. It was concluded
that no moveable parts or any part that could cause sparking should
be used in the design and additional precautionary measures should
be considered.
Electronic components
The LSR block diagram showing the potential configuration for the
unit indicates the use of an A/D converter for feedback to the
microprocessor controller. The question to be answered is whether
the output signal for the processor should be digitized. We do not
think that on-site processing is necessary or required but by using
telemetry, the original signal could be enhanced and evaluated
outside the space suit. For telemetry transmission, the
digitization of the signal will be beneficial.
Fliaht model from DrototvDe
Once the "Breadboard" design has been finalized, TSI will develop
the "Flight Model" which requires miniaturization of the prototype
and definition of connections, seals and packaging. The major
effort will be in the miniaturization, safety tests and approvals.
_@_ah order-of-maanitude price
TSI estimates the cost (in $U.S.) of developing a state-of-the-art
operational prototype to be $40,000 to $60,000 and telemetry
$15,000 to $20,000. EVA testing to be carried out by TSI and/or
NASA will require another effort of $20,000 to $40,000.
_lSt of purchasers of the DBMg008
Following are only some of the institutions and organizations which
have purchsed one or more of TSI's Ultrasonic Doppler Bubble
Monitors:
- DCIEM
- NASA
- U.S. Navy
- Royal Netherlands Navy
- Royal Australian Navy
- Scmidt Scientific Taiwan Ltd.
- Naval Experimental Diving Unit, U.S.
- Virginia Mason Hospital
- Pearls Pry. Ltd., Australia
- West Indies Laboratory
- The following U.S. Universities:
Concordia, Michigan, New Hampshire, Duke, Pennsylvania,
North Carolina, Florida State, Texas
UNIVERSAL SONICS CORP.

QUESTIONNAIRE
Your name: Ron Hadani Telephone #: 201 825-8414
Your organization: Universal Sonics Corp.
1. How many years has your organization been in the ultrasound
marketplace? 6 years.
2. How many cumulative engineering person-years of experience
does your current staff have in design of medical ultrasound
equipment? 98 years.
3. Does your organization have experience in design of
battery-operated, medical, ultrasound equipment (Y/N)?
Yes. If yes, approximately how many cumulative engineering
person-years? 2 years.
4. Does your organization have experience in design
flight equipment (Y/N)? Yes. If yes, explain:
of
Due to an arrangement for the exchange of engineers and
scientists with RAFAEL, the Armament Development Authority
of ISRAEL, Universal Sonics has employees with ten to
twenty years of experience in the development of miniaturized
and ruggedized flight equipment.
5. Does your organization have experience in design of
ultrasound equipment specifically for circulating
microbubble detection (Y/N)? Yes. If yes, please explain:
Universal Sonics has broad expertise in the design and
development of state of the art ultrasound systems. As a
supplier to many of the OEM's in the ultrasound field, we
provide subassemblies such as a Doppler modules, Doppler
Color Flow modules, ultrasound pulser/ receivers, Cine loop
boards, Beamformers etc., as well as complete imaging systems
and cardiac patient monitoring equipment.
6. What are your organization's unique strengths in the design
of ultrasound equipment?
Universal Sonics Corporation has broad expertise in the design
and development of state of the art ultrasound systems. As a
supplier to OEM's we provide subassemblies, such as Doppler
modules, Doppler color flow modules, ultrasound pulser/
receivers, Cine loop boards etc., as well as complete imaging
systems. Universal Sonics has also developed patient
monitoring equipment.
7. What patents or intellectual property does your
organization hold which could be relevant to this project?
A unique miniature pulser, capable of
with a 10 nanosecond risetime.
delivering 300 volts
Expertise in Cardiac output monitoring gained from the
development of such a monitor based on a CW Doppler with
probes monitoring the ascending aorta through the
suprasternal notch and the descending aorta using a trans-
esophageal probe.
A compact low noise CW/PW Doppler operating over the 2MHz to
10 MHz frequency range.
A unique Doppler Range-Gate Integrator design for improved
Signal to Noise in Doppler Color Flow front-end.
8. Will your organization be submitting a "Description of
Technical Approach" by Friday, November i, 1991 (Y/N)?
Ye___s
IN-SUIT ULTRASOUND BUBBLE DETECTOR FOR EVA
DESCRIPTION OF TECHNICAL APPROACH
i. General -
Universal Sonics Corp. will develop a small, battery
operated Doppler ultrasound based instrument capable of
monitoring micro-sized bubble activity in the blood
flow of an astronaut in a space suit. Once configured,
the instrument will operate unattended during EVA.
The system will consist of a low-profile, small array
of transducers and a Doppler Ultrasound Unit (DUU)
which will be located inside the space suit. The
acquired information will be telemetered to the space
vehicle to the Doppler Processing Unit (DPU). To
minimize power consumption and data storage
requirements, data will be sampled for 10 to 20 seconds
every several minutes. The information will be stored
in memory for future analysis in the DPU.
2. Development Program -
Universal will divide
three (3) phases:
the development program into
- Feasibility studies
- Breadboard design
- Flight model design
2.1 Phase 1 - Feasibility studies
During this phase Universal will identify, test and
evaluate the following:
* The best monitoring sites and transducer mounting
methods for these sites.
* The optimal operating frequency to maximize
microbubble sensitivity and minimize motion artifacts.
* Define telemetry method to be used.
* Define storage method to be used.
* Validate feasibility of meeting packaging and power
requirements of flight model.
PAGE 2 /_
2.2 Phase 2 - Breadboard design
During this phase Universal is planning to design and
develop a functional breadboard. The breadboard will be
the electrical equivalent of the flight model, but will
not meet the environmental, packaging and power
requirements. However, the design approach will reflect
the constraints of the flight model specifications
wherever possible.
2.3 Phase 3 - Flight model design
During this phase, Universal will develop the flight
model. The verified and approved circuitry of the
breadboard version will be redesigned and reimplemented
to meet the requirements of the flight model. This
version will require the use of surface mount and
custom I.C.'s to meet the packaging and power
requirements (i.e. volume, weight, temperature,
atmosphere etc.).
3. General technical approach -
Universal's approach will be based on a ____
wa_e$_[_p_. An array of split transducers will be
mounted inside the astronaut's space suit aiming
towards the monitored sites. The front end of this
Doppler will be based upon Universal's existing
technology. The transducers will be multiplexed
sequentially and the audio output of each site will be
telemetered to the DPU for analysis and storage. A
processor in the DPU will analyze the data and record
the time, location and occurrence of the bubbles, while
rejecting signals from body motion.
4. Estimated development charges -
The following are Universal's budgetary estimates for
the development time and charges:
Feasibility studies: 3 montlls $i00,000
Breadboard development: 9 months $350,000
PAGE 3
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APPENDIX G
Sample Ultrasound Transducer Patent (Abstract)

004279543 WPI Acc No: 85-106421/18
XRPX Acc No: N85-079779
Two-dimensional transducer array for ultrasound imaging provides
selective actuation of discrete element in planar array of elements
separated from each other acoustically and electrically; DOPPLER BLOOD
FLOW MEASURE MEDICAL DIAGNOSE
Index Terms: TWO-DIMENSIONAL TRANSDUCER ARRAY ULTRASONIC IMAGE; SELECT
ACTUATE DISCRETE ELEMENT PLANE ARRAY ELEMENT SEPARATE ACOUSTIC ELECTRIC
Patent Assignee: (GENE) GENERAL ELECTRIC CO
Author (inventor): BRISKKEN A F
Number of Patents: 004
Patent Family:
CC Number Kind Date Week
EP 139285 A 850502 8518
US 4530363 A 850723 8532
EP 139285 B 901227 9101
DE 3483868 G 910207 9107
(Basic)
Priority Data (CC,No,Date): US 543945 (831020);
Applications (CC,No,Date): EP 84112277 (841012);
EP and/or WO Language: English
EP and/or WO Cited Patents:
A3...8705; GB 2005835; US 4307613; US 4062237; US 4067236; US 4242912;
DE 2643918; US 4203162; 4.JnI.REF; US 3888238; I.JnI.REF
Designated States (Regional): DE; NL
Abstract (Basic): EP 139285
Sixty-one piezo-electric transducer elements (1-61) are provided
on the surface of a support member (152). A respective conductive lead
from each element connects through a cable (153) with the ultrasonic
system. By selection of the sequence of energisation of the channels
(1-61) for transmission, the acoustic beam is steered as required in a
direction disposed transversely of the surface. Similarly the sequence
of energisation of the elements for receiving an echo signal is scanned
as desired.
In a far-field application the array is energised to provide a
number of concentric annuli with the degree of focussing being
dependent on the number of annuli defined.
USE/ADVANTAGE - For non-invasive measurement of flow rate in blood
vessels at various depths in body tissue. Array can be operated in
sector scan mode and in focussed or unfocussed mode. Focussed array
has a widely-variable focal length. @(15pp Dwg.No.5/8)@
Abstract (US): 8532 US 4530363
A two dimensional transducer array includes a number of discrete
transducer elements in a planar pattern. Each element is electrically
and acoustically separated from others. The elements are selectively
actuated in one mode as a linear transducer array for sector scanning
and locating a vessel of interest.
The elements are selectively actuated in a second mode as several
annular arrays for far field focussing on the vessel for blood flow
measurements. The elements are actuated in a third mode as a central
disc and an outer annulus for near field focussing on the vessel for
blood flow measurements.
ADVANTAGE - Transducer array has widely variable focal length.
@ (8pp) @
Abstract (EP): 9101 EP 139285
Ultrasonic apparatus for measuring blood flow in a vessel
comprising a two dimensional array of ultrasound transducer elements
(151) arranged in rows and coloumns on a plane surface of a support
member (152), said elements being electrically and acoustically
separated from each other, means for energising selected ones of said--
transducer elements in a predetermined sequence so as to transmit
ultrasonic energy into the vessel and to receive ultrasound echo
signals from the vessel, the apparatus, being characterised in that t__
means for energising are arranged to provide any of the following
operating modes: (i) a sector scan mode, in which the transducer
elements are selected to form a linear array of groups of elements
which groups are excited successively so as to provide a sector scan
enabling location of a vessel to be measured, (ii) a near field Doppler
mode, in which either the transducer elements of a disc area or the
elements of this area together with those of an annular area
concentrically surrounding said disc area are excited simultaneously so
as to form alternately a narrow beam and a wide beam intercepting a
part or the whole of the vessel cross section, respectively, and (iii_
a far field mode involving the simultaneous excitation of the
transducer elements in each of a plurality of separate areas of said
two dimensional array, said areas comprising an inner disc area and a
plurality of annular areas . concentrically surrounding said disc area_
the areas being excited successively so as to provide a beam focused on
said blood vessel. @(llpp)@
File Segment: EPI
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Int Pat Class: G01S-015/89; GIOK-011/34; A61B-010/00
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A sensitive ultrasonicmethod'for _
diagnosing and mon/tor/ng venous air embolism--
a potentially fatal complication, occurring
dtu_g neurosurg/ca/procedures performed
in the upright position.
Recorder output responding
only to the presence of
air embolism.
Wide angle multi-crystal
monitoring transducer.
Electrocautery interference
rejection.
Simple transducer attachment.
SONtCAt[3
cardio_
A simple and sensitive method for diagnosing and
monitoring air embolism.
The Sonicaid D206E Air Emboli Detector is designed specifically
for use during operative procedures in which there is a risk of
venous air embolism. Using a Doppler ultrasonic technique the
early detection of a potentially fatal complication of venous air
embolism can be made allowing action to be taken before it
becomes apparent by other means of monitoring.
' The air embolism is detected
using a wide angle ultra-sound
monitoring transducer operating at
a frequency of 2MHz. Interfering
signals from such sources as
electrocautery are avoided by
sensing the signal and disabling
the audio and chart recorder output
for the duration of the interference.
Embolism Event Recorder
An important feature of the
unit is that a chart recorder drive
signal is provided. The signal is
processed so that it only responds
..... to air emboli thereby providing a
simple method for recording any
air emboli event that may occur
during the operation procedure.
Principle of Operation
_ .!._ : TheD206Egeneratesacont-_._ inuous 2MHz ultrasonic signal
_-_ _-----_ which is reflected by blood cells
and vessels. By use of the Doppler
_ : technique the reflected signalfrom
, ____ i m°ving structuresisc°nvertedint°_ an audible sound. When ai , in theform of an embolism, pass s
- 4_-\_. through the path of the ultrasoundsignal, a high-pitched "chirping"
or"scratchy" sound is produced by
- the change in 'reflectivity' at the
blood/air interface.
R_e_nmc_
1. Albin MS. Babii'ulki M. Maronn IC. t!t al: Ane,slhelic ma,a_emenl ol l_v, lh_rmr Itms_ surgery m the siltinR posilion.
Acla Ana_slh,._iol Sound 20:117- I:_& Lq76
2. Edmonds-S_l I. Po's-Robena U. AdemJ AP: Air *m_ooliwn. A cump_ri_n M wrmoJ rnmhoc_ of dm_._ioa.
Anueslhellia 2_;: 202-208. 1971
3. Michenielder ID. Miller REI. Gronurl GA: Evaluuliun ol iln ullnumnic tlevi(3- _ IL_)pplerl for the dial(no6is of venous air embolism.
Anesthesiolo_" 36: 164-167. 1972.
4. GildenherR p./. O'Rrien R.P. el el., "'The e[fiency ul L_)pph_¢ Mon ilortntt lot the L_lt_:lion or Venous Air F.mbolism".
[. Neurasurg. 54: 75-7& tgBI.
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OF POOR QUALITY
Sonicaid Limited Quarry. Lane. Chichester. West Sussex. POI9 2LP. England
Teh:phone:0243 775022 Teh,x: 865fl3 Cables: SomcaidChichester
Safety
Fullymains-isolatedpatient
circuitrydesigned toconform to
thefollowingspecifications:
IEC 601 Part I class1
BS 5724 Part I class 1
UL 544 & CSA C22.2 No. 125
(1979}
Power Supply
100 - 125V, 200 - 250V, 50/60Hz
8 RechargeableNickel-Cadmium
cells
Battery Life ( --
Approx. 10 hours between
charges.
Charging time 14 hours from full
discharge
Controls & Connectors
'Off/charging/on' switch
Volume control
'Power on' LED indicator
'Battery low'LED indicator
Transducer socket
Headset jack
Additional protective
Earth terminal
Waveform output
Fuses (2}
Accessories
Transducer, lycra bandage,
buckle, headset, tube aquasonic
gel, power cable, instructional
tape cassette, operating handbook,
spare fuses, minature jack plug. "-
Dimensions
185 x 270 x 195mm
Weight
3.25 kg, complete with accessories
_ _ _ .... ._ ...... ,. .____,_. ....
Please quote part Sonicaid --
numbers when ordering Part No.
D206E Air Emboli
Detector 8340-6902 --
(incl. accessories) 8340-6908"
Aquasonic 100[tube) 1300-0152
Aquasonic 100 --
(0.25 litre bottle) 1300-0153
Aquasonic 100
(4 litre container) 1300-0154
Monitoring
Transducer 8340-6901
Stethoscope Headset
Specifications aresubject to
chanoe withnut nntice_
- Instrument Description
The TC2-64 Transcranial Doppler is
a 2 MHz pulsed ultrasound Doppler
velocimeter for the examination of
intracranial and extracranial blood
vessels. It incorporates a built-in
64-point sliding-average FFT
spectrum analyzer with a 132
spectral line resolution on the 5"
(12 x 9 cm) monitor screen.
A choice of eight different velocity
scales (4 bidirectional, 4 unidirectio-
nal) display velocities of up to 400
cnVsec or alternatively as Doppler
shift in kHz (up to 10 kHz). Sweep
speeds of 3, 5, 8 or 15 seconds are
selectable and there is a frame
freeze facility.
A built-in computer ensures simplici-
ty of operation by adjusting such
parameters as p.r.f., low-pass
filters, etc., so as to optimize the
spectral display and minimizing
"aliasing" at high velocities. The
monitor also displays a symbol for
the direction of flow (towards or
away from the probe), depth of
the sample volume, cursor setting,
mean velocity, pulsatility index
(Gosling), patient ID number and
vessel label (if applied).
© EdenMedizinischeElektronikGmbH,
1989,All nghtsreserved.
The Doppler signal is reproduced by
a built-in loudspeaker, but the use
of the high-quality standard head-
phones is recommended. An
adjustment of the ultrasonic output
from 10 to 100% ensures that
safety recommendations can be im-
plemented without restricting flexi-
bility of operation. A gain control
adjusts the sensitivity of the spec-
trum analyzer to the strength of the
Doppler signal.
Digital/analog input/outputs permit
connection to video-printer, compu-
ter, strip-chart printer, monitors, etc.
Hard-copy documentation can be
provided by a dot-matrix or video
printer. Secondary functions of the
operating buttons are used to label
left and nght sides as well as main
intracranial vessels. A remote
control allows operation from the
bedside.
The TC2-64B Multifrequency
Transcranial Doppler is identical to
the TC2-64 with the addition of 4
and 8 MHz facility with a switchaD/e
probe holder.
Optional extras
A wide range of probes are availa-
ble for monitoring, pediatric and
other specialized extracranial and
intracraniai applications.
A quadruple-action foot-switch
leaves the hands free for compres-
sion manoeveurs.
The TC/PC Interface conveniently
connects the TC2-64 to a suitable
computer.
A clip-on vinyl pannier ensures safe
and easy transport of probes, gel
and accessories•
An upgrade kit is available to
upgrade the TC2-64 to the muttifre-
quency 'B' version.
Weight: 9.9 kg (21.8 Ibs)
Height: 15 cm (6 in)
Width: 41 cm (16 in)
Depth: 35 cm (14 in)
All dimensions without carrying
handle,
For further information on this or
any of EME's family of TCD instru-
ments, contact your local distributor
or EME directly.
Thisequipmentisdesignedandconstruc-
tedtoconformto therequirementsof IEC-
1 Class 1, UL 544, CSA C22 2 No: 125
(1979), BS 5724-1 Class 1, VDE 0750
andother internationalsafely standards.
Sincewe are continuallyseekingto
improveourproductsand to make use of
the latesttechnicalinnovations,these
detailsare subjectto change
withoutnotice.
Localregulationsmayrequiresome
variations.
Eden Medizinische Elektronik GmbH
Obernedweg 2, D-7770 Uberlingen
Lake Constance, W. Germany
Tel: (07551) 80980
Fax: (07551) 809825
Telex: (07551) 733970
Eden Medical Electronics, Inc.
19226 661h Avenue South
Suite L-103
Kent, Washington 98032 USA
Tel: (206) 656-8330
(800) 323-EDEN
Fax: (206) 656-8331
Versadopp ®10
i
O
Rotating Audio
Output Nipple
Adjustable
Volume Control
Pocket Clip
Battery
Battery Sleeve
Power Switch
Transducer
 i rGgn°sllq
souna
corporation
THE VERSADOPP 10 DOPPLER
The Versadopp 10 is a pocket sized, pulsed, ultrasonic
Doppler instrument which extends the capability of the ordi-
nary stethoscope; sensing blood velocity rather than only
detecting sounds.
SENSITIVE AT THE RIGHT DEPTH
The Versadopp 10 virtually eliminates noise from the mo-
tion of the instrument by not sensing depths near the skin
surface. When the power switch is depressed, ultrasonic
waves are transmitted from the transducer to arteries at depths
between 0.1 cm and 1.75 cm. A small amount of ultrasonic
wave energy is reflected and shifted slightly in frequency by
moving blood cells (Doppler shift effect).
The Versadopp 10 sensor receives the reflected wave en-
ergy, and translates the frequency shift into an audible signal.
This signal is amplified and transmitted through a stetho-
scopic headset, giving an accurate representation of blood
flow velocities. The Versadopp 10 tissue penetration range
is optimal for evaluating arterial flow; systolic blood pres-
sure, peripheral vascular disease screening, occlusion screen-
ing, mapping location of arteries for placement of catheters,
and penile arterial flow.
RUGGED AND CONVENIENT
The stainless steel housing is rugged enough for years of use,
and provides electromagnetic shielding from radio frequency
interference. A standard stethoscopic headset fits on the rotat-
ing, audio output nipple, allowing the instrument to be
positioned freely during use. The Versadopp 10 may be
sterilized by ethelene oxide gas (remove battery,) for use
intraoperatively, and covered by a latex probe cover for use
in isolation cases.
SAFE AND EFFECTIVE
The high receiver efficiency of the transducer provides tot
patient safety through the use of low ultrasonic power.
PRECISE FLOW SOUNDS
The single crystal design of the Versadopp 1(I provides flow
sounds more precisely related to t]ow velocities than older,
two crystal designs. Vascular professionals commonly
recommend holding the Versadopp 10 at a 45 degree
angle to the vessel being examined, for best performance.
Versadopp® 10
/
ACTUAL
SIZE
SPECIFICATIONS
ULTRASONIC FREQUENCY
TRANSDUCER DIAMETER
SENSING RANGE (DEPTH)
OUTPUT
BAIWERY
BA'I'TERY LIFE
DIMENSIONS
WEIGHT
10 megahertz (+ or - 3%)
6.5 mm
0.1 cm to 1.75 cm
Audio to standard stethoscope
(supplied)
4LR 44 or PX28L
Approximately 6 months
ordinary clinical use (PX28L)
16.25 cm X 1.65 cm
54 grams ( 1.9 oz)
/
WARRANTY
Parts: We will provide exchange pans free of charge for up to 5 years
from the date of original purchase.
Labor: We will repair the instrument free of charge for up to I year
from the date of original purchase.
This warranty does not apply to products repaired or aitert_l by anyone
other than the DIAGNOSTIC ULTRASOUND Corporation. The
DIAGNOSTIC ULTRASOUND Corporation shall not be liable for
con_quential damages. Since some states do not allow this exclusion
of limitation of con_quential damages. _me of this limitation may
not apply to you. This warranty gives you specific legal rights. 'and
you may also have other rights which vary from state to state.
OUR 30 DAY EVALUATION POLICY
If for any reason you arc not completely satisfied
with your Versadopp*10 Doppler. you may return
it in undamaged condition within 30 days for a
prompt 100% refund,
D .D..!agnostiquffrosouno
corporotion
_" I II I
] To order, call our toll free number(800) 331-2313
P.O. Box 0789
Kirk/and, Washington 98083-0789
(800) 331-2313
(206) 828-3860
FAX (206) 827-8324
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THE HOFFREL ""MODEL 518 SD+-
IMAGE + DOPPLER - DUPLEX
PIQggFI_
Ht_tlrt-,I In,,lruml, nt,_ Incorporated
MODEL 518SD+ CARDIOVASCULAR DUPLEX SCANNER
SYSTEM SPECIFICATIONS:
Scan Angle:
Frame Ride:
Scanning Deplh:
Video Gray:.
M-mode:
Zoom:
Meesumment Package:
Integrate:
SDC Display:
A-mode:
Video Immlm:
Depth merkere:
S¢41nControl:
Dull 9 '° Dle_ys:
Copy function:
Membrane Keyboard Front Plmel:
Remote Control:
Font_vf4ch control:
Audio:
Sector Reffeeh:
Cumor Scan:
Ghcmllng Gales:
Scanning Mo¢km:
Cunmr.
Gain:
Pui_
Pulse length:
PRF:
Amlldgu_/h_Ccot_.
Inl,gml_ Poldmold Cam, m or
MRlubllhl Video Prlrd_.
Sl_mm Anah,zer(FF13:
Video Cmmette Recc.rde_.
Storage bin:
Dimensions:
Powq_.
Selectsble 45, 60 and 75 degrees.
Selectable 15 or 25 frames per second,
Selectabls 2.5, 5. g, 14. tT and 25 centimeters.
2-D, 64 levels (8 seleclable positions)
M-moOa 16 levels {8 seleclaWe positions)
Spectral D)splay 16 levels
3 salectable Scroll Rates (Io. mecL hi) also moving bar display {Io, mad, hi),
Read only X2
Distance. Area. Perimeter calculations (joystick input). VelOCity calculation. Angle determination,
Frame to Frame integration tO help minimize noise
2-D and M-mode
Seiectable on/off (real lime)
Whole on Black/Black on White (2-D and M-mode)
2-0 and M-mode
Serve
Separate brightness and contrast controls.
Separate Freeze controls.
Hard COpy and/or Video tape of both displays.
Full 9" displays of 2-O, M-mode and Spectrum Analysis.
Both monitors turn left and right to facilitate viewing.
Input connectors for two transduceR, user selectable.
Durable, cleanable, resists coupling gel.
All spectrum Analyzer controls,
Video Cassette Recorder controls.
Mode, Freeze and Ham Copy.
Two channels @ 4 Wafts/channel
Automatic sector refresh (updates lector image) while performing doppler studms.
Automatic dopotar cursor scanning to view all the gates available dunng live sector
Allows operator to view any dot:)pler gate dunng 2-D.
A-mode. M-mode. 2-D
Vector curler continuously adjustable through 60 deg,
Transducer can be stopped anywhere in lector angle to perform M-mode or doppier studies,
Continuously vanlble control of: Power
Relect
Near
Far
SIo_e
Start
Multifrequency ooerellon: 2.0. 3.1, 3,8, 5.6. 7.SMHz.
Sample Gate Size {frequency dependent)
Man. 0.4 mm
Max. 6.2 mm
SelectBble 4, 8, 15 Cycles
3 selectable fixeO values for each probe frequency.
The values are: to/400 Lo.
to/280 Mid.
to/200 Hi
Alerts operator when the sample gate is out of allowaOfe sempling depth.
Max. 15,2cm (frequenCy dependent)
Front panel and foolswitc_ control
Autotuna: Aulomatic Selling of NOiSe Level and Dynamic Range wire manual ovemde,
Quantify: Automated calcuiat0on of beak frequency and mode frepuency.
Automated lime and frecluency curlor_.
Real-time clock and date display.
Vessel annotation display.
Remote control.
JVC BR6400U with remote control.
'/_ inch VHS format.
Direct dnve system.
4-he=a system.
Shuffle searcl_ at 10 limes normal speed.
Vanable-speeO playback from still to 5 times normal, in forward and reverse.
Selectable audio dubbing.
Front accessible.
Height 57", 145cm
Width 20,5", 52cm
Deptr_ 31". 78cm
Wheel Size 8", 20cm
Weight 398 Ibs., 181kg
120v/60Hz @ 6.1 amps (732 watts)
Integrated Isolation Transformer Specifications subject to
change without notice
CoDyl_t • 1gO6by Hofinlt Inltrumi_tl. Inc.
Hoffrel Instruments Incorporated, 345 Wilson Avenue, South Norwalk, CT 06854 (203) 866-9205
TELEX: 752745 HOFFREL UD
HPN227-00068(4/86)
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ULTRASOUNDBLOODFLOWDETECTOR
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THE ADVANTAGE OF HADECO TECHNOLOGY
• Hand held design
• Built-in speaker
• Five interchangeable probes
• Automatic power "OFF"
• Battery operated
• Printer Output
®M25
Doppler Ultrasound Probe Model P81
A large flat probe for use with MedaSonics
VERSATONE ® Doppler. Ultrasound
frequency" approximately 2.4 MHz.
voLUME
• Used during neurosurgical procedures per-
formed in the upright position for the de-
tection of venous air embolism.
• Improved shielding allows use of this
Doppler probe without electrocautery inter-
ference when VERSATONE is operated on
battery power.
• Detects internal motion-heart muscle.
heart valves, and blood flow.
• Probe incorporates two sending crystals and
two receiving crystals to give wide angle
coverage.
• Rapidly interchangeable with other VERSA-
TONE '_' Doppler probes.

